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ABSTRACT 
INVESTIGATION OF THE MECHANISM OF 
ADR1 MEDIATED TRANSCRIPTIONAL ACTIVATION
by
Philip B. Komamitsky 
University of New Hampshire, December, 1997
The purpose of these studies was to examine the mechanism of function of the 
transcriptional activator ADR1 of yeast Saccharomyces cerevisiae. ADR1 is required for 
the activation of the ADH2 gene, as well as genes involved in glycerol metabolism and 
peroxisome biogenesis. ADR1 is a DNA-binding protein. It binds to a 22 bp palindromic 
upstream activating sequence 1 (UAS1) element located 215 bp 5’ to the transcription start 
site of ADH2. Elements similar to UAS1 are found in promoters of all ADR 1-dependent 
genes. ADR1 was shown previously to contain three transcriptional activation domains 
(TADs): TADI (amino acids 76-172), TADH (263-357) and TADIH (420-462).
A novel activation domain, TADIV (residues 642-704), was identified in ADR1. 
Analysis of different derivatives of TADIV indicated that its activation function is 
principally localised to residues 698-704. In contrast to deletion of other ADR1 activation 
domains, deletion of activation domain IV from ADR1 severely compromised its ability to 
activate ADH2 transcription.
ADR1 activation domains have been shown to directly interact in vitro with 
ADA2 and GCN5 components of the ADA2 co-activator complex, and both ADA2 and 
GCN5 are also required for full ADH2 derepression. In addition, direct interaction of 
ADR1 TADs with TF1IB was observed, in which TADI displayed the strongest binding. A 
point mutation in TFDB that reduced ADH2 derepression was found to result in decreased
ix
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in vitro interaction of TJrJJU with TADI. These results suggest that THlK is a functional 
contact for ADR1 activation of transcription.
Defects in ADA2, GCN5 and THJLB do not severely reduce ADR1 ability to 
activate transcription, suggesting that there may be additional contacts that ADR1 makes 
with the components of transcriptional machinery. In order to identify these proteins, I 
examined which known components of the general transcription machinery are retained by 
the ADR1 activation domains from yeast whole cell extracts. It was found that ADR1 
transcription activation domain IV (TADIV) specifically retained core transcription factor 
HD. Moreover, ADR1 could be co-immunoprecipitated with the TAF90 component of the 
TF13D from yeast whole cell extracts. ADH2 activation by ADR I required the presence of 
intact TFUD in vivo, suggesting that the physical interactions that were observed had 
functional relevance.
We propose that multiple contacts made by the ADR1 activation domains to 
different components of the general transcriptional machinery and to the ADA2 co-activator 
complex contribute synergistically to the activation of the ADH2 gene. After facilitating the 
first rate limiting step - for example, TFUD recruitment, other steps in the preinitiation 
complex assembly become rate limiting, and even though transcription rate may have 
already become significant, it is further increased by ADR I establishing new contacts to 
TFHB and possibly other general transcription factors.
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
General Introduction.
The yeast Saccharomyces cerevisiae, when grown in the presence of glucose 
and a mixture of other carbon sources such as disaccharides, ethanol, or glycerol, are 
capable of selectively utilizing glucose only. This phenomenon is mediated by the 
repression of genes whose products are involved in carbon catabolic pathways other than 
glycolysis and is called “glucose repression”. Under repressed conditions, glucose is 
fermented, and the end product is ethanol. Respiration in yeast is almost completely 
inhibited under these conditions. Yeast cells are believed to acquire a selective advantage by 
depriving other organisms of glucose [Ronne, 1995]. After glucose is depleted, yeasts can 
then utilize the previously secreted ethanol while most other organisms would not be able to 
use ethanol as a carbon source. The first enzyme in Saccharomyces cerevisiae ethanol 
utilization pathway is ADH BE (alcohol dehydrogenase isozyme II) which catalyses 
formation of acetaldehyde from ethanol.
Yeasts contain three well characterized alcohol dehydrogenase isoforms - cytoplasmic 
ADH I and ADH II, and mitochondrial ADH ID. ADH I isoform is most abundant when 
glucose is used as a carbon source. Its amount is reduced approximately 5-fold when 
nonfermentable carbon sources, such as ethanol or glycerol are used [Denis et al., 1983].
In contrast, ADH II isoform is undetectable under glucose (repressing) growth conditions 
and becomes a major isoform of ADH under nonfermenting growth conditions, i.e., it is 
subject to glucose repression. One of the biochemical reasons for the yeast cell switching 
from ADH I to ADH II is that ADH C has a lower for ethanol [Wills, 1976]. ADH II 
therefore converts ethanol to acetaldehyde more efficiently than ADH I under the 
derepressing conditions, when acetaldehyde concentration in the yeast cell is very low 
(Figure I).
1
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
Figure 1. Alcohol dehydrogenases in yeast metabolic pathways
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Genes that are subject to glucose repression include gluconeogenic enzymes, 
Krebs cycle enzymes, components of the mitochondrial respiratory chain, peroxisomal 
proteins and ADH n. Glucose repression is achieved both at the posttranscriptional and 
transcriptional level. mRNA levels of some genes fluctuate by as much as 800-fold when 
yeast cells are shifted from a repressing carbon source, such as glucose, to derepressing 
conditions. In most cases this change is due to a dramatic increase in transcription, 
although some effects on mRNA stability have also been reported. For instance, a major 
determinant of the steady-state level of the mRNA encoding the iron protein (Ip) subunit of 
succinate dehydrogenase of yeast is its rate of turnover. This mRNA is significantly more 
stable in glycerol than in glucose media [Cereghino, 1996].
The molecular mechanisms underlying glucose repression are not completely 
understood, and the signal transduction pathway effecting glucose repression is largely 
unknown. The glucose itself or an early metabolite are not the triggers of the glucose 
repression pathway. It has been suggested that the repression is triggered by the glycolytic 
flux rather than by an early intermediate of glycolysis [Ronne, 1995].
The increase in the transcription rate of glucose-repressible genes occurs either by 
removal of negatively acting factors or by action of positive factors, or both. The 
mechanisms of transcriptional activation and repression in eucaryotes have been an area of 
intensive research for a number of years. A very large number of genes had been implicated 
in both processes. The genes participating directly in either process could be tentatively 
divided in two subgroups: one including genes whose products interact with or 
posttranslationally modify components of the general transcriptional apparatus and the other 
including genes involved in the maintenance or modification of chromatin.
The widely accepted model of DNA-binding transcriptional activator function 
proposes that these proteins, after binding to specific DNA sequences located in the
3
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proximity of the transcription start site of the promoters, strongly interact with some 
components of the general transcriptional machinery and in turn bring them down to the 
promoter. This facilitates the assembly of a protein complex which is capable of 
transcription initiation. The minimal set of factors required for reconstituting accurate in 
vitro transcription initiation by RNA polymerase II includes TFUA, TFHB, Tb'ilD, 
TbilE, Tbilh, and RNA pol II [Wang et al., 1992]. Since it had been established that the 
assembly of the initiation complex is an ordered process, i.e., every component joins the 
complex at a designated stage, it should be possible to identify the rate-limiting step in the 
process of the assembly of initiation complex on a given promoter. This step then should 
be the primary target of an activator, although considering that the formation o f the 
initiation complex involves the interplay of many factors, other scenarios are also possible. 
In vitro studies with purified or partially purified components of general transcriptional 
apparatus have shown that TFUD binding to DNA is rate-limiting in vitro for at least 
some promoters, suggesting that this step represents a likely target for transcriptional 
activators. The observation that many activators work synergistically suggests that more 
than one step in the initiation complex assembly may be affected at once.
The sequential model of assembly of the initiation complex evolved in recent 
years with the discovery of the RNA polymerase II holoenzyme [Koleske and Young, 
1989]. The largest subunit of RNA pol II, encoded in yeast by the gene RPB1 has an 
unusual C-terminal structure, which consists of head-to-tail heptad repeats of the proline- 
rich sequence YSPTSPS. Truncation of a part of these repeats results in the inability of 
yeast carrying such a truncated RPBl to grow at 16°C. This feature was used to select for 
mutations which would suppress temperature sensitivity and led to identification of a group 
of nine genes, called SRBs. SRB proteins turned out to be physically associated with RNA 
polymerase II in a protein complex which was named RNA polymerase H holoenzyme. 
Further analysis of the holoenzyme revealed that not only SRBs, but also such previously
4
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identified general transcription factors as TFELH, TH1F, and TFIUB are associated in a large 
complex prior to the assembly on a promoter. The direct implication of this observation in 
the context of the activation of transcription is the substantial reduction of a number of steps 
required for assembly of the initiation complex. It also limits the number of steps that can 
be affected by an activator. It was suggested that the recruitment of the holoenzyme to the 
promoter is a one-step process [Carey, 1995].
DNA-binding transcriptional activators do not necessarily contact components of 
the general transcription machinery directly. A number of proteins have been found to be 
required for activated transcription but which are dispensable for basal transcription. Some 
of these proteins were shown to physically associate with transcriptional activators and 
were named co-activators or adaptors. These proteins are believed to mediate the activation 
of transcription by bridging DNA-bound transcriptional activators and the components of 
general transcriptional machinery. In yeast, co-activator function was attributed to the 
ADA2 complex and in mammals a number of co-activators had been described, for example 
CBP/p300, p/CIP, PCAF, TBP-associated factors (TAFs). Interestingly, it was found that 
many of the co-activators posess histone acetyltransferase activity, suggesting that they 
may mediate transcriptional activation in part by modifying chromatin structure at the target 
promoters.
Nucleosomes (chromatin) present a significant obstacle for the transcription 
factors in that it reduces the accessibility of DNA binding sites. A number of proteins have 
been identified in recent years that are capable of changing chromatin structure by 
modifying nucleosomes postranslationally or physically rearranging them. The influence of 
these factors on transcription can be both repressing or activating depending on what kind 
of modification they bring about. The specificity of the effect of chromatin modifying 
factors (i.e., how these factors locally modify chromatin at a particular promoter) is 
achieved via interaction with specific DNA-binding proteins or via incorporation of these 
factors into the general transcription apparatus. Protein complexes identified to date that are
5
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believed to be required for relieving the repressive structure of chromatin include the 
SNF/SWI complex, some of the SPT factors [Bortvin et al., 1996; Dollard et al., 1994], 
the RSC complex [Cairns et al., 1996], the ADA2/GCN5 complex in Saccharomyces 
cerevisiae , and a number of similar protein complexes in Drosophila, mice and humans. 
The nature of chromatin modification caused by SNF/SWI or RSC complex is unknown, 
and probably does not involve covalent modification of histones. The SNF/SWI complex 
was found to be tightly associated with the RNA polymerase II holoenzyme [Wilson et al., 
1996]. The GCN5 component of multiprotein ADA2/GCN5 complex is a histone 
acetyltransferase, which is capable of acetylation of some of the lysine residues in the 
histone N-termini. GCN5 is required for activated transcription of some, but not all, yeast 
genes [Brownell at al., 1996, Candau et al., 1997]. Several other histone acetylases 
(HATs) playing a role in transcription have been identified to date, for example TAF250, 
CBP, pCIP [Mizzen et al. 1996, Yang et al., 1996]. Since the acetylation of histones 
results in relieving repression caused by chromatin at some promoters, the removal of 
acetyl residues from histones should result in the opposite effect. Indeed, a number of 
recent reports have appeared linking histone deacetylation with transcriptional repression. It 
was demonstrated that in yeast transcriptional repression by Ume6, a negative regulator of 
genes involved in meiosis, is mediated by recruitment of the Sin3/Rpd3 complex. Rpd3, a 
component of this complex and a histone deacetylase, can efficiently repress transcription 
by itself when brought to DNA by fusing to a heterologous DNA-binding domain 
[Kadosh, 1997]. Similarly, the mouse homolog of yeast Sin3, mSin3A, mediates 
transcriptional repression by Mad/Max heterodimer, and mSin3 A is a component of large 
multiprotein complex with histone deacetylase activity essential for effecting repression 
[Hassig, 1997].
The research presented in this thesis is aimed at identifying the molecular 
mechanisms by which activation of the ADH2 gene is achieved by its transcriptional 
activator ADR 1.
6
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When glucose is removed from the growth medium and yeast are forced to grow 
on a nonfermentable carbon source, ADH2 transcription is derepressed and ADH II activity 
increases 500-fold [Ciriacy, 1975]. DNA sequences located -176 to -453 bp upstream of 
the ADH2 transcription start site are required for regulated ADH2 transcription [Beier and 
Young, 1982]. Two upstream activating sequences in this region, UAS1 and UAS2, were 
shown to be required for full derepression of the ADH2 gene. The 22 bp palindromic 
UAS1 had been shown to bind transcriptional activator ADR1, and UAS2 is believed to 
bind an as yet unidentified factor which acts synergistically with ADR1 to activate ADH2 
transcription (Figure 2).
ADR1 had been cloned [Denis et al., 1983] and sequenced [Hartshome et al, 
1986]. It contains 1323 amino acids, and immunoprecipitation from yeast crude extracts 
reveals that the protein has a MW of 150 kDa [Vallari et al, 1992]. Residues 1-16 of ADR1 
were found to be necessary for its nuclear localization [Thukral et al., 1989]. The DNA- 
binding domain of ADR1 is located in the N-terminus of the protein spanning residues 72- 
176. This domain contains two zinc fingers of Q H j type (Figure 3), and mutation analysis 
had shown that this region is essential for ADR1 function and DNA binding [Thukral, 
1989]. Zinc fingers of Q H j type are also found in many DNA-binding proteins, for 
example IMIIA [Miller et al., 1985], Spl [Kadonagaet al., 1987], Zif268 [Pavletich and 
Pabo, 1991], and Krox20 [Nardelli et al., 1991]. More detailed analysis of the 72-176 aa 
region suggested that besides being a DNA-binding domain this region also has a 
transcriptional activation function. First, expression of ADR1 fragment 72-176 or 1-220 in 
a yeast strain deleted for ADR1 resulted in ADH2 derepression [Cook et al., 1994].
Second, some of the mutations in this region resulted in a loss of its ability to activate 
transcription from a heterologous promoter while apparently having no effect on DNA 
binding [Cook et al., 1994a]. Taken together, these observations designated amino acids 
72-176 as transcriptional activation domain I (TADI).
7
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Figure 2. ADH2 promoter structure
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Deletion analysis of the ADR1 protein revealed two additional regions important 
for activation of transcription that were localized to residues 262-288 (TADII) and 420-462 
(TADIII) [Cook et al., 1994a, Young E.T., unpubl. observ.] (Figure 3). These fragments 
of ADR1 were also able to activate transcription when fused to a heterologous DNA- 
binding domain. Deleting both TADH and TADIII from the full length ADR1 protein 
resulted in the decrease of its activation potential. Deletion of any single one of these 
domains, however, had very little or no effect on ADR 1-mediated activation. This result 
suggested that TADII and TADIII have partially redundant functions in transcriptional 
activation, presumably by affecting the same step in the activation process.
A substantial number of trans-acting factors other than ADR1 have been 
implicated in the regulation of ADH2 gene expression (Figure 4). They can be divided into 
two groups based on the effect on ADH2 expression. One is comprised of genes whose 
products are required for ADH2 derepression to occur, and mutations in these genes result 
in complete or partial derepression defects on nonfermentable carbon sources. The second 
group includes genes required for glucose repression, and mutations in these genes result 
in improper expression o f ADH2 when glucose is present in the growth medium.
The first group includes ADR1, CCR1/SNF1, CCR4, CAFl, and components of 
the SNF/SWI complex. CCR1/SNF1 is a protein kinase whose activity is required for 
derepression of all glucose repressible genes, CCR4 is a component of a large protein 
complex whose other components are NOT1, NOT3 and a number of CAFs (CCR4 
Associated Factors) and the precise role of this complex in transcription is not very well 
understood [H.-Y. Liu, pers. commun.]. Many of the components of this complex, 
including CCR4 itself, are well conserved among eucaryotes. SNF/SWI proteins are 
involved in nucleosome rearrangements, and mutations in those genes lead to mild defects 
in ADH2 derepression. Also required for full ADH2 derepression are some of the SPT 
genes, such as SPT3 and SPT7 [Denis C. L., unpubl. observ.], whose function is believed 
to be related to the TATAA box selection by TFUD.
10
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The second group of genes, mutations in which allow partial escape from glucose 
repression, includes chromatin remodeling factor SPT6 (CRE2), another member of the 
Spt group of proteins - SPT10 (CRE1) [Denis, 1984], and the gene partly responsible for 
glucose repression at the ADH2 locus, REG I [Dombek et al., 1993]. Surprisingly, a set 
of dominant mutations in the ADR1 gene was isolated that allowed partial escape from 
glucose repression. All these mutations were amino acid substitutions in the narrow region 
of the ADR1 protein, amino acids 227-239. Deletion of this region from ADR1 also led to 
the partial escape from glucose repression. Since this region represented a consensus 
sequence for cAMP-dependent protein kinase (cAPK) phosphorylation, and some of the 
mutations leading to partial derepression of ADH2 drastically reduced the ability of cAPK 
to phosphorylate this region, it was concluded that ADR1 activity is regulated 
posttranslationaly and that cAPK phosphorylates and inhibits ADR1 activity under 
fermentative growth conditions [Cherry et al., 1989]. However, additional experiments 
[Denis et al., 1992] proved this not to be the case: yeast strains with no detectable cAPK 
activity still were able to normally repress ADH2 on glucose, and a number of mutations in 
the 227-239 region while allowing glucose-insensitive ADH2 expression did not affect the 
ability of cAPK to phosphorylate this region. Based on these observations, as well as on 
the fact that the 227-239 region when fused to a synthetic activator reduces the synthetic 
activator ability to activate transcription [Cook et al., 1994], it was suggested that the 227- 
239 region binds a repressor protein. Yet another region of ADR1 which allowed partial 
escape from glucose repression as well as higher level of ADH2 expression under 
derepressing conditions was mapped by deletion analysis to amino acids 282-330 [Cook et 
al., 1994a].
Since ADR1 plays a pivotal role in ADH2 derepression, the transcriptional and 
translational effects of glucose on ADR1 were extensively investigated [Vallari et al., 1992, 
Cook, 1994a]. It was found that ADR1 protein level is reduced 5- to 8-fold in glucose
12
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versus ethanol grown strains, and ADRl mRNA level is reduced approximately 2-fold. 
Two-fold reduction of ADR1 mRNA level appears to result from the increased degradation 
rate of ADR1 mRNA when yeast are grown in the presence of glucose, which is dependent 
on a long 5’-untranslated region found in ADR1 mRNA. ADRl mRNA half life in a strain 
grown in glucose-containing medium is 45 min. compared a half life of 110 min. when 
ethanol is present as the carbon source. The much more significant reduction of ADRl 
protein level in glucose-grown cells is due to the reduction of ADRl protein synthesis, and 
this effect is mediated by the region of ADRl encompassing amino acids 262-642 of the 
protein. A recent report [Dombek et al., 1997] indicates that the reduction of ADRl protein 
level under fermentative growth conditions is mediated via the cAMP-dependent protein 
kinase pathway. An interesting observation made by Vallari et al., 1992 indicates that the 
reduction of ADRl level on glucose plays a functional role in regulation of ADH2 
expression: an 8-fold dosage increase of ADR1-5C allele, resulting in the ADR1-5C protein 
level on glucose similar to the ADRl protein level on ethanol in a strain carrying single 
copy of ADRl gene, gives the level of ADH2 expression on glucose identical to that for the 
single copy ADRl-containing strain on ethanol. This observation indicates that a 
combination of post-translational modification or interaction with repressor protein and 
reduction in the ADRl protein level contributes to the glucose repression of the ADH2 
gene.
The analysis of sequence features of ADRl TADs provided little clue as to the 
mechanism of their function. No significant similarity to the activation domains of other 
transcriptional activators from yeast or other eucaryotes was found. The comparison of 
transcriptional activation domains from a variety of activators allows one to outline only 
very general sequence features characteristic of transcriptional activation domains. One 
class of these domains contains acidic residues interspersed with bulky hydrophobic amino 
acids and is predicted to form amphipathic a-helices. However no conclusive experimental
13
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proof that these sequences actually form amphipathic a-helices exist. Some experimental 
evidence [Sainz et al., 1997] indicates, that contrary to expectations, introduction of a - 
helix - incompatible prolines into transcription activation domain of maize activator Cl 
which is predicted to form an amphipathic a-helix, has no effect on Cl function. Recent 
experiments with the VP 16 activatior showed that the activation domain is most likely an 
unstructured coil which is induced to undergo a significant structural alteration, presumably 
to an a-helix, upon binding to the human TAF31 [Uesugi et al., 1997]. Two hydrophobic 
residues and an aspartate were found to make direct contacts with hTAF31. The second 
class of the transcription activation domains is comprised of glutamine-rich activation 
domains. An example is the well described human transcriptional activator Spl. 
Interestingly glutamine-rich transcriptional activators do not function in yeast, and the 
reason for this failure to activate transcription is believed to be the absence of the 
appropriate mediator of activation (co-activator) in yeast cells.
The focus of this dissertation is to elucidate the mechanisms of ADR I-mediated 
activation of ADH2. In order to address this problem, the approach was taken to identify 
proteins that physically interact with ADRl or its individual activation domains and to use 
genetic techniques to study the effect of these proteins on ADH2 transcription in vivo. It 
was found that ADRl TADs make multiple contacts to components of basal transcriptional 
machinery and to coactivators. Using protein affinity chromatography and 
immunoprecipitation techniques specific interaction of ADRl with coactivators GCN5 and 
ADA2 and with basal factors TFTIB and TFUD was demonstrated. Deletion of GCN5 or 
ADA2 genes negatively affected ADRl mediated ADH2 derepression. Targeted depletion 
of a TAF90 component of the TFQD was found to completely prevent ADH2 derepression.
14
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Chapter I.
The identification of factors, interacting with the ADRl activation 
domains. Identification of Transcription Activation Domain IV.
Introduction.
Three activation domains had been previously identified in the ADRl protein: 
transcription activation domain one (TADI; amino acids 72-176), which overlaps with the 
DNA-binding domain, TADII (amino acids 262-359), and TADIII (amino acids 420-462) 
(Figure 3). The sequence of these activation domains did not reveal significant similarity to 
any of the previously found transcriptional activators. TADIII amino acid composition is 
fairly acidic (10 acidic residues out of 30 in the 421-456 region), and the structure of this 
region partially agrees with the consensus sequence of the acidic activation domains of such 
Saccharomyces cerevisiae transcriptional activator as GAL4, and viral activator VP 16 
[Cook, 1994a]. A fourth region (642-1323) has been implicated for efficient peroxisomal 
gene expression [Simon et al., 1995] and was presumed to contain a cryptic activation 
domain. The precise function of the C-terminal region of ADRl had been, however, 
unknown. In order to investigate the function of this region, we tried to identify other yeast 
proteins that may interact with it using the two-hybrid system [Fields and Song, 1989]. In 
our two-hybrid experiments we used the DNA-binding domain of the Escherichia coli 
LexA protein fused to residues 642-1323 or 1-262 of ADRl and the GALA transcriptional 
activation domain or synthetic transcriptional activation domain B42 fused to the yeast 
genomic fragments (Figure 5).
15
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Prey- protein of interest fused to the activation domain 
Bait- another protein of interest fused to the DNA binding domain 
DBD- DNA binding domain 
DRS- DNA recognition sequence
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M aterials and Methods.
Yeast and Escherichia coli strains, growth conditions and enzvme assays.
Yeast strains are listed in Table 1. Conditions for growth of yeast cultures on 
minimal medium or YEP medium, containing either 8% glucose or 2% ethanol have been 
described elsewhere [Cook et al., 1994]. YD8 solid medium contained YEP supplemented 
to 8% glucose and 2.5% agar.
All subcloning and DNA manipulations were conducted in Escherichia coli 
DH5a strain.
B-galactosidase assays were conducted on yeast extracts as described elsewhere 
[Cook et al., 1994]. ADHII activity was assayed as described elsewhere [Denis, 1987].
Plasmids.
LexA202 plasmids are multicopy 2|i plasmids and have been previously 
described [Ruden et al., 1991]. The 34 “reporter” plasmid is a 2fi based plasmid containing 
eight LexA operator sites, controlling the LacZ gene [Brent and Ptashne, 1985]. The JG4-5 
vector as well as yeast genomic library based on this vector have been described elsewhere 
[Zervos et al., 1993]. The pPC86 vector and the library with GAL4 transcriptional 
activation domain have been described elsewhere.
Plasmid pJKlOl used in the transcription interference assay contains GAL1 
promoter with LexA operator inserted 3’ to the UASG and was constructed as described 
[Cook et al., 1994a and references therein].
The construction of plasmids LexA^-ADR1-642-1323 and LexA ^-A D Rl-l- 
220 is described elsewhere [Cook et al., 1994a].
17
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Table 1. Yeast Strains
Strain Relevant Genotype
EGY188 MATa ura3-52 his3 leu2 trpl LexAop-LEU2
938-9b MATa ura3-52 his4 LexAop-LEU2
YEK20 MATa ura3 his3 trpl leu2 suc2 ade2 Iys2 taf25::TRPl pRS413-HA 1 ,-TAF25
yBY40-8’ MATaura3 his3 trpl leu2 suc2 ade2 lys2 taf90::TRPl pRS413-HAl3-TAF90
EGY188-aifl MATa ura3-52 his3 trpl LexAop-LEU2 aifl::URA3
EGY188-gl MATa ura3-52 his3 trpl LexA0p-LEU2 gcn5::URA3
PSY3I6 MATa ade2-I01 his3-A200 leu2-3, 112 lys2 ura3-52
PSY316-ada2 MATa ade2-101 his3-A200 leu2-3, 112 lys2 ura3-52 ada2::URA3
YMH130 MATacycl his3M leu2 trpl ura3-52 sua7::LEU2 adel pRS313-SUA7
GMY26 MATa ade2-101 his3-A200 leu2-3, 112 lys2 ura3-52 gcn5::URA3
CY26 MATa ade2-101o his3-A200 Ieu2-Al trpl-A l lys2-801a ura3-52
CY57 MATa ade2-101o his3-A200 Ieu2-Al trpl-A l lys2-801a ura3-52 swi2::HIS3
612-Id MATa ura3 his3 leu2 trpl adhl-11
612-ld-al MATaura3 his3 leu2 trpl adhl-11 ada2::URA3
612-1d-g1 MATa ura3 his3 Ieu2 trpl adhl-11 gcn5::URA3
612-ld-6a MATa ura3 his3 leu2 trpl adhl-11 caf6::LEU2
1005-2-3b MATaura3 his3 leu2 trpl sptlO::TRPl adh 1-11
787-6b MATa adhl-11 adrl-l::ADRl-5c-TRPl ura3 Ieu2his3 trpl
40-lc MATaura3 his3 trpl adhl-11 adrl-l::ADRl-TRPl
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Plasmid construction
Deletion of amino acids 642-704 from the full length ADRl was conducted as 
described [Appendix A]. The resulting pBR322-41 IBaTADIV was cut with SstI and 
SnaBI and ligated to pAK52, cut with the same restriction enzymes. The resulting 
construct, pAK52ATADIV was then digested with BstEII, blunt ended with the large 
subunit of Escherichia coli DNA polymerase I (Klenow), and subsequently cut with 
Ncol. An ADRl fragment containing residues 1-642/704-1323 was ligated into pLexA202- 
5, which was digested with Xhol, blunt ended with the Klenow enzyme, then cut with 
Ncol. This procedure yeilded LexA^-ADRl aTADIV. Since in this construction the 
junction between LexA and ADRl moieties differed from that of the original LexA^- 
ADR1, the new LexA^-ADRl with the identical sequence of the junction site was 
constructed. To construct LexA^-ADRl fusion deleted for residues 675-704, ADRl from 
pAK52 was PCR amplified with two primer pairs. Amplification with pair one gave ADRl 
fragment 1-675 with Ncol at 5’ end and EcoRV site at 3’ end. Amplification with pair two 
gave fragment 704-1323 with EcoRV site at the 5’ end and Sail site at 3’ end. Fragment 
one was digested with Ncol and EcoRV, and ligated into pGEM3Zf that had been digested 
with the same restriction enzymes. The resulting construct was digested with EcoRV and 
Sail and the PCR product corresponding to the fragment 704-1323 (digested with the same 
enzymes) was ligated into it. pGEM3Zf-ADRlA675-704 was cut with Ncol-Sall, and the 
ADRl moiety was ligated into LexA202-5 digested with the same enzymes, resulting in 
LexA^-ADR IA675-704.
The full length A IF l gene was isolated as described below, and subcloned into 
pUC19. The resulting construction was cut with Ncol and Sail, generating frill length 
AIF l which was ligated into LexA202-5 vector digested with the same enzymes.
19
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The LexA^-AIFl containing only the C-terminal fragment present in the library 
clone was constructed by cutting the library clone with EcoRI, and ligating the resulting 
AIFl fragment into pLexA202-l cut with the same restriction enzyme.
Plasmid rescue from veast cultures
In order to obtain sufficient amount of plasmid DNA for cloning and sequencing 
purposes, plasmids need to be rescued from yeast and transformed into E. coli. The yeast 
strain containing the plasmid to be rescued was grown overnight in liquid culture in 2 ml of 
the appropriate selective medium supplemented with 2% glucose. Yeast cells were collected 
by centrifugation at 1000 g, and washed in 5 ml of TE. Washed cells were resuspended in 
500 m l TE buffer, 200 units of glucilase were added to the tube and yeast cells were 
incubated with glucilase at 30°C for I hour in the shaker. Yeast cells were transferred to a 
microcentrifuge tube, collected by centrifugation at 500 g, and gently washed in 1 ml TE. 
Cell pellets were resuspended in 200 m l Cell Resuspension Buffer (Promega Corp., 
Magic Miniprep), 200 ul of Cell Lysis Buffer (Promega Corp., Magic Miniprep) and 120 
m l 10% SDS was added and mixed thoroughly. The suspension was boiled for 5 minutes, 
then 300 m l Cell Neutralization Solution (Promega Corp., Magic Miniprep) was added 
and the mixture was kept at 4°C for 10 minutes. After centrifuging for 5 minutes at 6000 g 
in a tabletop microcentrifuge, 600 m l of the supernatant fluid were mixed with 1 ml of 
DNA Binding Resin Slurry (Promega Corp. Magic Miniprep), and the protocol for 
Promega Corp. Magic Miniprep was then followed. Five ml of rescued DNA solution was 
used to transform Escherichia coli DH5a strain.
Isolation of clones, sequencing and homology search
The LexA^-ADR1-642-1323 truncations and AIF clones were rescued from 
yeast cells as described above and sequenced by using the Sanger dideoxy method or by
20
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PCR-based cycle sequencing at the UNH Sequencing Facility. The full length clone of the 
AIFl gene was isolated from the yeast genome cosmid 9315 containing a fragment of 
yeast chromosome VIII.
Sequence comparisons were performed at the National Center for Biotechnology 
Information using the BLAST Web service [Altshul et al., 1990].
Western Blotting
Western blot anslysis of LexA and B42 fusion proteins was performed as describedby 
others [Draper et al., 1994]. To detect LexA fusions, rabbit polyclonal antibodies raised 
against the LexA 1-202 fragment were used. Commercially available mouse monoclonal 
12CA5 anti-HAl antibodies were used to detect HA 1-tagged B42 fusion proteins.
21
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R esu lts .
P art I.
Identification of the Transcription Activation Domain IV of ADRl.
With the use of the two-hybrid system, we sought to identify proteins interacting 
with ADRl. The transcriptionally inactive ADRl fragment spanning residues 642-1323 
was fused to the LexA DNA binding domain [Cook et al., 1994a]. The vector expressing 
this fusion protein was introduced into yeast strain EGY188 containing two reporters: 
LexAop-LEU2 at the chromosomal locus and LexAop-lacZ on a 2(i-based high copy 
vector. EGY188 with LexAap-LEU2, LexAop-lacZ and expressing LexA-ADR 1-642-1323 
was unable to grow on Leu' selective plates and B-galactosidase activity in this strain was 
<5 milliunits/mg protein. The strain was also white on plates containing X-gal, because of 
the absence of B-galactosidase activity.
A yeast library, containing genomic fragments fused to the GAL4 transcription 
activation domain, under the control of the ADH1 promoter, was transformed into this 
strain. The total number of transformants obtained was lxlO6. This number is sufficient to 
represent every gene in yeast genome with a 99% probability.
After the transformation, yeast were plated on Ura'HisTrp'Leu' selective plates 
and incubated at 30°C. The Ura' selection is used to maintain plasmid borne LexAop-lacZ, 
His' selection maintains the LexA202-ADRl-642-1323 expressing plasmid, Trp' selection 
maintains the library plasmid, and the only yeast cells that were able to activate the LexAop- 
LEU2 reporter were able to form colonies on Ura'HisTrp'Leu' selective plates. Such 
colonies were picked, plated on Ura'HisTrp'Leu' selective plates containing X-gal to test
22
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for the activation of the LexAop-lacZ reporter. Finally, colonies that were able to activate 
both LexAop-lacZ and LexAop-LEU2 reporters were tested for the dependency of the 
observed activation on the presence of library plasmid. The library plasmid containing the 
TRPI selectable marker was lost from the cells by repeatedly streaking them to single 
colonies on Ura'His' plates that do not select for the maintenance of the TRPI gene. 
Colonies that lost TRPI were tested for the ability to activate LexAop-LEU2 and LexAop- 
lacZ reporters. Surprisingly, in all colonies tested the activation of both reporters did not 
depend on the library plasmid. Further analysis indicated that the ability to activate the 
reporter genes was linked to the LexA^-ADR 1-642-1323 containing plasmid. Rescuing 
the LexA ^-A D R1-642-1323 from the colonies that were able to activate LexAop-lacZ and 
LexAop-LEU2 reporters and re-transforming them into the original strain containing both 
reporters resulted in reporter activation.
Western analysis indicated that in all cases the truncation in the ADRl moiety of 
the LexA^-ADR 1-642-1323 has occurred (Table 2). The 56 isolates analysed were 
subdivided into 9 groups according to the apparent size of the truncated derivative. The B- 
galactosidase activities of the isolates were very close within each group, and the B- 
galactosidase activity correlated with the truncation size, the longest truncation derivative 
having the highest transcriptional activity.
Sequencing of 2 representative clones from each truncation group revealed the 
premature stop codons corresponding to amino acids 675 (group 1), 679 (group 2), 687 
(group 3), 692 (group 4), 694 (group 5), 698 (group 6), 701 (group 7), and 704 (group 8) 
of ADRl. The corresponding S-galactosidase activities for each group are listed in Table 2. 
Since the 642-704 fragment of ADRl was capable of activating transcription when fused 
to LexA DNA binding domain, we tested the effect of deletion of this small region on the 
transcriptional activation potential of the full length ADRl protein. Deleting the amino acids 
642-704 resulted in the 20-fold reduction of the LexA^-ADRl-1-1323 fusion ability to
23
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Table 2. Transcriptional activity of LexA202-ADRl-(642-1323) truncation 
derivatives.












P-Galactosidase activities were measured as described in Appendix A. Values represent 
averages of at least three separate transformants in the strain EGY188. S. E. values were 
less than 20%. The LexA reporter was pl840 in all cases.
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activate transcription of the LexAop-lacZ reporter gene (Table 3). To study the effect of 
amino acids 642-704 deletion on the ADRl transactivation of its physiological target, the 
ADH2 gene, this region was deleted from the chromosomal copy of the ADRl gene by a 
one step intergation procedure [Rothstein, 1991]. The ADRl allele deleted for amino acids 
642-704 had a 30-fold decreased ability to activate ADH2 transcription. The ADRl deleted 
for TADIV was also unable to support growth of Saccharomyces cerevisiae on oleic acid 
[C. L. Denis, pers. commun.] in agreement with the previously reported importance of C- 
terminal part of the protein for growth on this carbon source [Simon et al., 1995]. An 
ADR1-5C allele deleted for residues 642-704 was also severely defective in ADH2 gene 
activation. Adding back amino acids 642-675 did not restore the activity of LexA^-ADRl 
fusion to the wild type levels (Table 3).
The ability of amino acids 642-704 to activate transcription when fused to a 
heterologous DNA-binding domain as well as the importance of this region for the ADRl 
function led us to designate the residues 642-704 as transcriptional activation domain IV 
(TADIV).
The BLAST homology search of the Genbank database did not reveal strong 
similarity of TADIV to any of the previously identified transcriptional activation domains. 
The TADIV region had weak similarity to a region of yeast transcriptional activator ZMSI 
(37.1% identity in 35 residues overlap, Figure 6). ZMS1 contains other similarities as well: 
a highly homologous Zn-finger region with two C y ^  type fingers, and a region highly 
resembling the ADRl 227-239 region (Figure 6). No data are available on the function of 
the TADIV-like region in the ZMS1 protein.
The analysis of the TADIV sequence with the Protean program from DNA Star 
software package gives conflicting secondary structure predictions depending on the 
algorithm used. While residues 660 to 669 and 680 to 689 are predicted to form alpha 
helices by both Gamier-Robson and Chou-Fasman methods, the region of amino acids
25
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Figure 6. Pairwise alignment of ADRl and ZMSl.
Results of SIM with:
Sequence 1: adrl, (1323 residues) 
Sequence 2: zmsl, (1380 residues)
using the parameters:
Comparison matrix: BLOSUM62 
Gap open penalty: 12 
Gap extension penalty: 4
1. Zn-fingers of ASR1 and ZMS1
62.3% identity in 61 residues overlap; Score: 222.0; Gap frequency: 0.0%
adrl, 100 KLRSFVCEVCTRAFARQEHLKRHYRSHTNEKPYPCGLCNRCFTRRDLLIRHAQKIHSGNL
zmsl, 147 KPRPFLCPTCTRGFVRQEHLKRHQHSHTREKPYLCIFCGRCFARRDLVLRHQQKLHAALV
2 . C-region of ADR1 and its homology to a region of ZMS1
55.6% identity in 18 residues overlap; Score: 46.0; Gap frequency: 0.0%
adrl, 222 LKKLTRRASFSAQSASSY
zmsl, 336 MHKTKRHASFSASSAMIY
*  *  * * * * *  * *  *
3. TADIV region of ADR1 and its homology to a region of ZMS1
37.1% identity in 35 residues overlap; Score: 68.0; Gap frequency: 0.0%
adrl, 632 PAVSELNEYLDLFKNNFLPHFPIIHPSLLDLDLDS
zmsl, 786 PTTSQLNDYVTYYKEEFHPFFSFIHLPSIIPNMDS
*  ★  * ★  *  *  *  *  *  * *  * *
The alignment shown was performed by the LANVEW  program. Only sequence 
fragments with homology to ADR1 Zn-fingers, C-region and TADIV are shown.
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Table 3. The effect of deleting TADIV on ADR1 function.
ADHD









ADH Et activities were conducted as described in Appendix A. P-Galactosidase activities 
were determined as described in Appendix A in strain EGY188. S. E. values were less than 
15%. LexA ^-A D Rl, LexA ^-A D R l-A t^-TM  and LexA202-ADRl-A642-675 represent 
LexA-1-202 fused, respectively, to the full length ADR1 protein and to the full length 
ADR1 protein whose residues 642-704 or 642-675 have been deleted. All ADR1 proteins 
integrated at ADR1 chromosomal locus as well as all fusion proteins were expressed to 
comparable levels in vivo (data not shown). ADR1, strain 40-Ic; ADR1-A642-704, same 
as 40-lc except adrl-l::ADRl-A642-704-TRPl.
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698-704, contributing most of the activation potential to the TADIV is predicted to form 
alpha helix by Gamier-Robson algorithm and beta sheet by Chou- Fasman (Figure 7). The 
distinguishing feature of this region is the abundance of bulky hydrophobic tyrosine 
residues.
28
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Figure 7. Secondary structure preduction o f  the ADR1 T A D IV
Secondary structure prediction was performed wit the DNA Star software package module 
“Protean”. ADR1 residues 642-704 were analyzed. Residue 1 in the figure corresponds to 
residue 642 of ADRl.
■  Alpha, Regions - Gamier-Robson
■ Alpha, Regions - Chou-Fasman
□  Beta, Regions - Gamier-Robson 
B Beta, Regions - Chou-Fasman 
B Turn, Regions - Gamier-Robson
■ Turn, Regions - Chou-Fasman 
D Coil, Regions - Garnier-Robson
■ Hydrophilicity Plot - Kyte-Doolittle
□  Alpha, Amphipathic Regions - Eisenberg
□  Beta, Amphipathic Regions - Eisenberg 
Q Flexible Regions - Karplus-Schulz
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Part II.
Isolation of protein factors interacting with the ADR1 
amino acids 1-262.
The two-hybrid screen for interacting proteins was also conducted with the 
LexA ^-A D Rl-1-262 fusion. This fusion is transcriptionally inactive in spite of the fact 
that it includes TADI residues. The screen with JG4-5 vector-based yeast genomic DNA 
library was conducted by Dr. Yueh-Chin Chiang. The expression of B42-(genomic 
fragment) fusions in this vector is under the control of the galactose-inducible GAL1 
promoter. This feature substantially alleviates the analysis of the dependency of activation 
of the reporter gene(s) on the B42 fusion, since its expression can be turned off if glucose 
is a carbon source and turned on if galactose is a carbon source.
Thirty seven yeast colonies were isolated from this screen whose ability to 
activate LexAop-LEU2 and LexAop-lacZ reporter genes was dependent on the plasmids 
carrying
B42-fused yeast genomic fragments. These plasmid clones were rescued from yeast cells 
and organised into 4 groups based on the identity of the restriction digestion patterns. 
Western analysis indicated that each group of clones expressed a protein of larger size than 
the B42 alone, suggesting that an open reading frame fused to B42 is present in every case. 
Retransformation of the rescued library clones into parental strain restored its ability to 
activate reporter genes. The strength of interaction between LexA ^-A D R l-1-262 and 
different library clones varied substantially based on the measured p-galactosidase activity 
values (Table 4).
Library clones from each group were sequenced and BLAST search was 
conducted with every sequence obtained. The results of the BLAST search are summarized 
in the Table 4 . The genes were named AIFl through 4 (ADR1 Interacting
31
Reproduced w ith permission o f the copyright owner. Further reproduction prohibited w ithout permission.













AIFl 170 92 YNL144c No
AIF2/MAF1 120 66 None Yes
AJDF3 160 45 None No
AIF4 27 120 SNF2 family Yes
JG4-5 2 N/A N/A No
The four proteins that were shown to interact specifically with LexA-ADR 1-1-262 are 
shown on the left. JG4-5 is the B42 activation domain without yeast inserts. The ability of 
the B42-AIF fusions to interact with LexA-ADR 1 or LexA is given as a function of their 
ability to activate LexAnp^LacZ (p34) reporter. Interaction with LexA-AIFl was monitored 
by the ability to activate both LexA0p^LEU2 and LexAnp^LacZ (p34) reporters. [3-
Galactosidase activities were determined as described in Appendix A in strain EGY188. S. 
E. values were less than 15%.
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Factors 1 through 4). AIFl is a highly acidic protein, AIF2 is identical to MAF1, a protein 
whose mutations are implicated in missorting MOD5 (tRNA modifying enzyme) to the 
nucleus [Murawski et al., 1994], and AIF4 is a SNF2 family member. I further 
concentrated on the analysis of AIFl, which gave the highest P-galactosidase activity 
values and thus quite likely was the strongest interactor with LexA ^-A D Rl-1-262.
The AIFl gene encodes an 800 residues long protein with a very acidic C- 
terminus. The library clone isolated in the screen contained only 400 C-terminal amino 
acids of the protein. The full length AIFl clone was isolated from the chromosome V U I1- 
262, in contrast to the B42-AIF1-C-terminal interacted with this ADR1 fusion cosmid 9315 
as described in “Materials and Methods” . This clone was used to construct full length B42- 
AIF1 fusion. This fusion failed to interact detectably with LexA^-ADR 1 -rather strongly.
Interestingly, the LexA^-AIFl fusion protein interacted in the two-hybrid 
system with AIF2 and AIF4 library clones in terms of a blue/white screen. In contrast, the 
four AIF proteins failed to interact with a  number of other LexA fusions which we 
examined. It was further determined that other LexA ^-A D R l-1-262 constructs which 
differed solely in their sequences joined to LexA moiety or C-terminal to residue 262 were 
incapable of interacting with any of the AIF proteins [Y.- C. Chiang, pers. commun.]. 
These data suggest that non-ADR 1 determinants of the original LexA^-ADR I - 1 -262 
fusion contributed significantly to its interaction with the AIFs.
The disruption of AIFl and AIF2 resulted in no apparent ADH2 phenotypes.
The analysis of the yeast genome database revealed a presence of close homolog of AIFl in 
yeast (Figure 8). It is possible that the functional redundancy masks the effect of AIFl 
deletion on the ADH2 locus.
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Figure 8. Similarity of AIFl to YNL144c
The alignment shown was performed by the BLAST program at the National Center of 
Biotechnology Information.
Score = 648 (228.1 bits). Expect = 3.8e-86, Sum P(3) = 3.8e-86 
Identities = 130/303 (42%), Positives = 190/303 (62%)
AIFl: 9 LKSPSSSSTCSMDEVLITSSNNSSSICLETMRQLPREGVSG QINIIKETAASSSSH 64
LK ++S+ SM +■ + SS S+SI + ++ + NI+ E S
YNL144C: 20 LKLSQTASSISM3DEFLCSSTTSNSILDSPLPKVTFNHIDSITDIOTNIMNEIVEPQSGV 79
AIFl: 65 AALFIKQDLYEHIDPLPAYPPSYDLVNPNKEVRFPIFGDTAPCPKSSLPPLYAPAVYELT 124
+++ IDP P PP YD NP+K +R+PI+- PC S PP Y P-t-V T 
YNL144c: 80 DVDVADKNVLYCIDPYPVEPPCYDFANPSKVIRYPIYEHCRPCLTSVKPPSYTPSVEHYT 139
AIFl: 125 LISLKLERLSPYEISSNRSWRNFIIEINSTQLNFYHIDESLTKHIRNYSSGETKSEKEDR 184
++S+K+E+LSP+E +S+R W NFI++INSTQ+NFY ID+SLT+HI+NY G+
YNL144c: 140 WSMKMEKLSPFENASSRLWNNFXLQINSTQINFYSIDDSLTRHIKNYRGGEMFDHSH—  197
AIFl: 185 IHSDLVHRSDQSQHLHHRLFTLPTRSASEFKKADQERISYRVKRDRSRYLTDEALYKSFT 244
HS SD+ L T+S +F K D+ERI + RD ++L+DE L+KS++
YNL144c: 198 -HSKTA— SDRHHSARSLLNAFTTKSTYQFDKYDKERICGEIARDEHKFLSDERLFKSYS 254
AIFl: 245 LQNARFGIPTDYTKKSFVLRMSCESEQFLLRFSHIDCMIEWSMYLSIGISVSLDLEVREY 304
LQ A+ G+P DY+ + FVLRM CE +QFL++FSH+D++I W+MYL++GIS+SLDLE+RE 
YNL144c: 255 LQCAKVGLPIDYSSRDFVLRMRCEGQQFLVQFSHVDELIYWAMYLNM3ISLSIiDLELREM 314
AIFl: 305 PDYRIVP 311
P YR VP 
YNL144c: 315 PTYRSVP 321
Score = 192 (67.6 bits). Expect = 3.8e-86, Sum P(3) = 3.8e-86 
Identities = 41/101 (40%), Positives = 61/101 (60%)
AIFl: 678 TLSCFSNIPYGTDDIKWKPAIKEISRRRYLRDSLKCIKPFLDSNDCLGKVTYIPVSGPTF 737
+L C N ++D KW PA + +SR+RY++DSL+CIKP + + +GK+I+ P P F
YNL144c: 626 SLKC-GNKNQSSNDSKWAPATQLVSRKRYIKDSLRCIKPLTEDHPWVGKIIFKPALPPAF 684
AIFl: 738 ETSNK-IH-FSNRQS— LQKQKNHFLKGFIVGPTALIELNCK 775
ET+N I +S S L KNH+LK +IVG ++ K
YNL144c: 685 ETNNPPIRVYSGEDSTDLMHVKNHYLKPYIVGSCGFLKTGSK 726
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D iscussion .
The search for proteins interacting with ADR1 fragments 1-262 and 642-1323 
resulted in the identification of 4 proteins capable of interaction with the 1-262 region, and 
revealed the fourth activation domain, TADIV, localized to the residues 642-704 of ADRL 
No proteins interacting with the 642-1323 region were found.
The importance of the TADIV region for the function of the ADR1 is clear from 
the effect the deletion of residues 642-704 has on the activation potential of ADR1 both at 
the ADH2 locus and at the heterologous promoter of LexAop-lacZ reporter. Moreover, the 
642-704 fragment of ADR1 by itself is capable of transcriptional activation when fused to a 
LexA protein DNA binding domain. The deletion of this region from the full length protein 
has a substantially stronger effect on ADR1 ability to activate transcription than the deletion 
of any one of the previously identified activation domains [Cook et al., 1994]. It is 
important to note, however, that the ADR1 fragment comprising only amino acids 1-642 is 
capable of strong activation of transcription. In fact this fragment is a better activator than 
full length ADR1A642-704. This observation suggests that C-terminal part of ADR1, 
residues 704 to 1323, may partially block the activation by the three N-terminal activation 
domains in the full length protein. Elements of sequence similarity of this region of ADR1 
to self-repressive regions of some other yeast transcriptional activators [Poch, 1997] 
supports this suggestion. The sequence analysis of TADIV reveals that it contains a number 
of bulky hydrophobic residues in the 698-704 region, which by deletion studies is 
suggested to be especially important for TADIV function. The impotance of hydrophobic 
residues for function of other transcriptional activators has been described previously 
[Leuther at al., 1993, Drysdale et al., 1995, Jackson et al., 1996]. These residues are 
believed to participate in hydrophobic protein-protein interactions.
Four proteins were identified that contact a TADI-containing fragment of ADRl. 
The analysis of effects of disruption of these genes on the ADH2 locus did not reveal clear
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effects. The reason for the absence of effects may be that other yeast proteins perform 
redundant functions for those analyzed at the ADH2 locus. The presence of a protein in 
yeast (Open Reading Frame YNL144C, chromosome XIV) with the sequence highly 
similar to that of AIF1 supports this notion. Further study of AIFs will be required to 
understand their function.
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Chapter II.
ADR1 activation domains contact the histone acetyltransferase GCN5 and 
the core transcription factor TFIIB. 
In troduction .
The presence of four activation domains in the ADR1 (TADI (76-172), TADII 
(263-357), TADIII (420-462), and TADIV (642-704)) suggests that ADR1 may interact 
with multiple transcriptional cofactors and/or components of general transcriptional 
machinery. The observation that TADII and HI are functionally redundant [Cook et al., 
1994] suggests that some of these interactions may be with the same protein.
There are a number of potential targets for ADR1 activation domains. Core 
transcriptional components including TBP, TFIIB, TFIIF, TFIIE, and TAFs have been 
implicated in mammalian system as being direct contacts for transcriptional activators 
[Choy and Green, 1993]. In addition to these general transcriptional machinery 
components, other cofactors or coactivators may mediate the action of activators. The 
ADA2 complex is one such coactivator complex. The ADA2 complex has been shown to 
bind activators like GCN4 and VP16 [Bariev et al., 1995, Silverman et al., 1994] and to be 
required for maximal transcriptional activity of several yeast activators [Berger et al.,
1992]. The ADA2 complex has been also shown to bind TBP, and it was suggested that 
this complex acts as a direct mediator between activators and the general transcriptional 
machinery. However, some yeast activators like GAL4 or HAP4 [Berger et al., 1992,
Pina et al., 1993] are only slightly or not at all affected by defects in the ADA2 complex.
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Recent experiments indicate that the GCN5 component of the ADA2 complex is a 
histone acetyltransferase [Brownell et al., 1996]. Since chromatin structure at the promoter 
had been shown to have a strong effect on transcription and the acetylation of histone N- 
termini “loosens” chromatin and makes DNA more accessible, it was suggested that 
activator recruitment of the ADA2 complex results in targeted histone acetylation which 
allows for activated transcription to occur.
The analysis of chromatin structure at the ADH2 promoter found that one 
nucleosome is positioned over the TATAA box and another on the transcription start site 
under repressing conditions, and they are removed in an ADR 1-dependent fashion during 
ADH2 derepression [Verdone et al., 1996]. The UAS1 sequence to which ADR1 binds is 
not covered by a nucleosome under either repressing or derepressing conditions which may 
explain why mutations in such chromatin remodeling proteins as components of SNF/SWT 
complex have little effect on ADH2 derepression.
We found that mutations in AD A2 and GCN5 severely compromise the ability of 
ADR1 TADs to activate gene expression. In addition, we demonstrate that there is strong 
physical interaction between ADA2 and GCN5 and ADR1 TADs in vitro. TADIV binding 
to GCN5 was shown to directly correlate with TADIV activation function. TADs I and IV 
were also shown to make specific contacts to TFIIB. The interaction of TADI with the 
TFHB is specifically impaired by a point mutation in TFIIB which in vivo leads to two­
fold reduction of th&ADH2 derepression. These results suggest ADR1 TADs activate gene 
expression in yeast through direct physical contacts with multiple proteins including 
components of the ADA2 complex and the core transcriptional component TFIIB.
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Materials and Methods.
Yeast Strains.
Yeast strains are listed in Table I. Strain EGY188 was used for transformation 
with plasmids expressing LexA^-ADRl fusion proteins. The ada2::URA3 and 
gcn5::URA3 disruptions in strain PSY316 were a gift from L. Guarente, strains CY26 and 
CY57 were provided by C. Peterson, strain YMH130 and all isogenic strains containing 
mutant TFIIB alleles were provided by M. Hampsey.
Plasmid constructions.
Isolation of LexA^-ADR1-642-704 and and its truncation derivatives, as well as 
construction of LexA202-ADRl-D642-704 and LexA202-ADRl-D675-704 is described in 
Chapter I of this thesis. All other LexA^-ADRl fusions are described elsewhere [Cook et 
al., 1994a, Appendix A]. The construction of all GST fusions is also described in 
Appendix A. Plasmid vectors used for one step gene replacements of ADA2, GCN5, and 
ADH1 were described previously [Appendix A and references therein]. Construction of T7 
in vitro expression vectors of different TFIIB alleles was conducted by PCR amplifying 
TFIIB from a pM plasmid series provided by M. Hampsey, using primers which introduce 
unique Bgffl and Ndel sites at 5’ and 3’ end of TFIIB open reading frame, respectively. 
PCR products were digested with Bgin and Ndel, and digestion products were 
subsequently ligated into the T7 expression vector pETI la  [BioGen], which was 
previously digested with BamHI and Ndel and treated with calf intestinal phosphatase. All 
other T7 in vitro expression constructions were constructed as described elsewhere 
[Appendix A].
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Transformations. Enzvme assays and Growth Conditions.
All yeast transformations were conducted by using the lithium acetate method [Ito 
et al., 1983]. ADHII and B-galactosidase assays were conducted as described [Cook et al., 
1994]. Conditions for growth of cultures on minimal medium lacking uracil and histidine 
or YEP medium containing either 8% glucose, 2% ethanol and 2% glycerol, or 3% ethanol 
have been described elsewhere [Cook et al., 1994].
In vitro binding assay.
Conditions for in vitro binding assay are described in Appendix A.
Disruptions of ADA2. GCN5 and ADH I.
All disruptions were conducted according to the one-step gene replacement 
protocol [Rothstein, 1991]. The disruption vector containing the GCN5 gene replacement 
cassette was digested with Xhol and Sail and transformed into strain 612-Id, the 
disruption cassette for ADA2 replacement was cut with BamHI and Xhol and transformed 
into strain 612-Id, the disruption of ADH1 was done by transforming BamHI digested 
pHH20 disruption vector into strain YMH130.
Plasmid shuffle.
YMH130 yeast strain deleted for the chromosomal copy of the SUA7 gene 
(TFIIB) and containing an adhl::URA3 disruption and the plasmid-borne TFIIB allele on 
a ///Si-marked single copy plasmid vector was plated on 5-fluoroorotic acid plates to select 
for mutants in the URA3 gene. The YMH130 strain with adh2::ura3mttt was subsequently 
transformed with the C//?A3-marked single copy vector containing SUA7. Transformants 
were subsequently allowed to lose the H/55-marked S(M7-containing vector. The resulting
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strain was transformed with a set of mutant SUA7 alleles on HIS3-marked vectors. 
Resulting transformants containing wild type SUA7 on a C/RA J-marked vector and mutant 
sua7 alleles on /fJSi-marked vectors were plated on 5-FOA plates to select for the loss of 
wild type SUA7.
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R esu lts .
In order to identify the factors through which the four individual ADR1 TADs act, 
the effect of deleting different general transcription cofactors or adaptors on LexA-ADRl- 
TAD transactivation has been analyzed. The results, described in detail in the Appendix A, 
can be briefly summarized as follows: ADR1 TADI, H, III and IV were capable of binding 
to the GCN5 and a GCN5 deletion resulted in 2 to 3-fold reduction of the ADH2 gene 
derepression; ADR1 TADI and IV interacted with the core transcription factor TFIEB, and 
interaction of TFIIB with TADI was substantially stronger than with TADIV.
We further analyzed the TFDB role in the ADH2 derepression. Random PCR 
mutagenesis of SUA7gene conducted in Dr. Michael Hampsey laboratory yeilded a number 
of TFIIB derivatives containing single or multiple amino acid substitutions and defective in 
supporting growth at 37°C or 16°C. We have analyzed three of these mutant derivatives of 
TFIIB for their effect on ADH2 transcription (Table 5). The sua7-9 allele (encoding 
TFUB-9), containing E202G and F289S amino acid substitutions, was found to reduce 
ADH2 derepression by two-fold. The in vitro binding assay conducted with this mutant 
protein demonstrated (Figure 9) that its binding to TADI is severely diminished compared 
to the binding of wild type TFIIB or another mutant allele which has no effect on the 
ADH2 derepression. In contrast, TH1B-9 was unaffected in its binding to TADIV (Figure 
9), suggesting that the observed decrease in the interaction with TADI is not due to the 
gross structural change in the TFDB-9. The binding of other alleles of sua7 , which 
conferred reduced levels of the ADH2 derepression, to the ADR1 TADs is currently being 
investigated.
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Table 5. Effect of point mutations in SUA7 (TFIIB) on ADH2 derepression






ADH II activities were conducted as described in Appendix A. S. E. values were less than 
20%. Values shown represent averages of at least three separate measurements for each 
SUA7 allele. WT, strain YMH130; TFLLB-9 (mutations E202G, F289S), same as 
YMH130 except pRS313-sua7-9; TFI1B-30 (mutations T200I, K314M), same as 
YMH130 except pRS313-sua7-30; TFDB-31 (mutation L284Q), same as YMH130 except 
pRS313-sua7-31
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F ig u re  9. Binding of ADR1 TADI and TADIV to mutant 
variants of TFIIB.
m  m  c q
LL E  E
i—  i—  i—
_  >  _  > _  >
Q  Q  Q  5  Q  Q< < < < < <-  H H P=H PP
3 h  P P  3 h  P P  0. 0) 0) 0) 0. 0) 0> 0> 0. 0) 0> 0) £  (3 (5 0  C ( j o ( j C ( u ( j ( 3
TFIIB
Binding studies between GST fusion proteins indicated and radiolabeled wild type ( T H I h - 
wt) and mutant (TFI1B-9, -31) variants of TFIIB were conducted as described in the 
Appendix A. Amount of each GST fusion loaded on the gel is equivalent for all samples 
loaded.
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D iscussion.
ADR1 is the primary transcriptional activator of the ADH2 gene and has been 
shown previously (Cook et al. 1994a) and herein to contain four separable domains capable 
of activating transcription. These individual activation domains were found to be highly 
dependent on a functional ADA2 complex for their ability as LexA fusions to activate a 
LexA reporter system. Full length ADR1 fused to LexA still displayed, however, a 
significant, albeit reduced, activation function when the ADA2 complex was inactive. The 
activation domains in full-length LexA-ADR 1 must also be capable of binding targets in 
addition to the ADA2 complex [Appendix A].
Since we observed that ada.2 or gcn5 deletions did not completely block ADR1 
activation in all promoter contexts, it is likely that the ADR1 TADs make multiple contacts 
in promoter specific ways. It is known that the TADs play different roles at different 
promoters. TADI is solely required by ADR1 for maximal activation at the FOX2 and 
FOX3 promoter, but not at either ADH2 or CAT1. TADEH, on the other hand, is required 
for genes expression involved in glycerol mutations [Bemis and Denis 1988; Cook et al. 
1994] for which TADH is less important. TADIV alone plays a crucial role for activation 
of some unknown genes involved in peroxisomal biogenesis [Simon et al. 1995].
Therefore, in some promoter contexts a particular TADI interaction may be especially 
strong or essential, perhaps as modulated by chromatin structure and/or other promoter 
specific binding factors.
There are a number of potential targets for transcriptional activators. We showed 
that TFHB could bind TADs I and IV of ADR1 but neither TADs II or HI. TBP did not 
display any selective binding to any of the four TADs. These results are to be contrasted 
with that of GAL4 whose activation domain retains TBP but not TFIIB. The physiological 
relevance of these interactions is not certain. For TADIV of ADR1 and for the GAL4 
activation domain, mutations or deletions which clearly decreased their functions also
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directly reduced binding to TFIIB and TBP, respectively. Additionally, point mutation in 
TFHB that reduced ADH2 derepression had a stong negative effect on TADI interaction 
with TFIIB. This suports the biological importance of the interaction. It could also reflect 
that a particular region of TADIV or GAL4 is sticky and that TFIIB or TBP represent 
examples of proteins that could bind to the activator.
In any case, these results strengthen the case for examining a direct link between 
ADR1 and TFIIB using more genetic or in vitro experimental approaches.
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Chapter III.
ADRl-mediated transcriptional activation requires the presence of an intact 
TFIID complex. 
Introduction:
In the Chapter I of this thesis and in our earlier report [Appendix A] we had 
shown that individual activation domains of ADR1 contact TFIIB and histone 
acetyltransferase GCN5 in vitro. However, the deletion of GCN5 and a point mutation in 
the TFIIB which dramatically reduced its binding to ADR1 had only moderate effects on 
the derepression of ADH2 gene, suggesting the existence of additional activation 
mechanisms.
There are a number of potential targets for ADR1 activation domains among the 
core transcription factors. TFIID, TFI1F, TFIIB, RNA polymerase II, TFHH and TFTTF. 
have been implicated in mammalian and Drosophila systems as being direct contacts for 
various transcription activators. For example, glutamine-rich activation domain of Sp I 
contacts TFIID component dTAFl 10 [Hoey et al., 1993], VP16 interacts with TFIIB, TBP 
and histone - like dTAF42/hTAF31, yeast GAL4 binds TBP and TFIIB [Gupta et al.,
1996, Wu e al., 1996]. In vitro studies have shown that activators have both qualitative 
and quantitative effect on TFIID binding to the TATA box [Klemm et al., 1995]. It has 
been also demonstrated that the TFIID binding step is first and rate-limiting in the assembly 
of the initiation complex at many promoters [Shykind et al., 1997, Colgan et al., 1992], 
making it a likely target for transcriptional activators.
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TFIID is a multimeric complex consisting of TATA box binding subunit TBP and 
TBP associated factors (TAFs) [Poon et al., 1995]. Both TBP and TAFs show significant 
degree of evolutionary conservation throughout the eucaryotic kingdom [Burley et al., 
1996, Moqtaderi et al, 1996], suggesting that TFIID quaternary structure may also be 
conserved. Thirteen yeast TAFs have been cloned to date, with sizes ranging from 17 to 
150 kDa [Tansey et al., 1997]. Most of these proteins are encoded by essential genes. The 
precise role of TAFs in transcription is largely unknown. In vitro data suggest that these 
proteins are required for activated transcription and that they can serve as direct targets in 
vivo for activation domains of DNA-binding transcriptional activators of higher eucaryotes 
[Hoey et al., 1993, Klemm et al., 1992, Sauer et al., 1996]. In vivo data, however, 
indicate that yeast TAFs are not universally required for pol II transcription and are 
dispensable for activated transcription of a number of yeast genes [Moqtaderi et al., 1996, 
Walker et al., 1996]. Although encoded by essential genes, temperature sensitive alleles of 
yTAFl30/l45 and yTAF90 affect expression of only a small fraction of yeast genes 
[Walker et al., 1996, Apone et al., 1996]. Similar results were observed when different 
TAFs were eliminated from the yeast cell using a double shut-off method [Moqtaderi et al., 
1996].
We have found that ADR1 transcription activation domain IV can specifically 
retain TFIID from yeast whole cell extracts and that overexpressed ADR1 co- 
immunoprecipitates with yTAF90. Moreover, transcriptional activation of the ADH2 gene 
does not occur in vivo if the yeast cell is depleted of TAF90. These results suggest that 
transcriptional activation of the ADH2 gene by ADR I is mediated through its contacts with 
the TFIID complex.
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Materials and methods:
Strains and culture conditions:
Yeast strains are listed in Table 1. Strains 938-9b and yB Y40-8’ were used for 
transformation with plasmids expressing ADR1 from the G3PDH promoter. Strains 
ZMY60 and ZMY68 were a gift from Z. Moqtaderi and K. Struhl. For the TAF90 shut-off 
assay, ZMY60 and ZMY68 were grown in synthetic media lacking uracil (SC-Ura), 
supplemented with 5% glucose, until they reached 0 0 ^ =  0.3. At this time CuS04 was 
added to a final concentration of 500 [iM, and incubation was continued for another 7 
hours. Yeast cells were washed twice in SC-Ura supplemented with 3% ethanol, 500 (iM 
CuS04, and incubated in this media for 6 hours. Aliquots were taken at 0, 1,2 and 6 hour 
time points. For the preparation of yeast whole cell extracts yeast strains containing ADR1- 
overexpressing plasmid were grown in synthetic media lacking leucine (SC-Leu), 
supplemented with 3% ethanol, 3% glycerol or 5% glucose to the O D ^  = 0.7. All other 
strains used in this work were grown in YEP supplemented with 3% ethanol, 3% glycerol, 
to the ODgoo = 0.7.
All DNA manipulations and subcloning were done in E. coli DH5a strain. GST 
fusion proteins were expressed and purified from E. coli BL21 strain.
Plasmid constructions: The vector expressing full length ADR1 from G3PDH 
promoter was constructed by cutting pJClOO [Cherry, 1988] with BamHI and Hind m  and 
isolating the fragment containing the entire G3PDH promoter and residues 1-649 of ADR1 
and ligating it into pRS425 [Christianson, 1992] digested with BamHI and Hindin, 
creating pPK46. pAK52 containing the entire ADR1 gene with approximately 1.5 kb of 3’ 
sequences, was cut with BstEII, blunt ended with Klenow enzyme, cut with Hind EH and
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the fragment containing residues 649-1323 of ADR I was isolated from the agarose gel. 
pPK46 was cut with Sal I, blunt ended with Klenow enzyme, cut with Hind in and ligated 
to the amino acids 649-1323 ADR1 fragment, creating pPK47 containing full length ADR1 
under the control of the G3PDH promoter. pPK50 containing full length ADR1 deleted for 
TADIV was constructed by cutting pPK47 with Nco I and Bsg I, isolating the vector 
backbone from the agarose gel, cutting pPK4 [Appendix A] with the same enzymes and 
ligating pPK4 fragment containing ADR1 residues 1-642-704-1200 into pPK47 backbone.
GST fusions of ADR1 TADs and Vpu were constructed as described in Appendix 
A. Isolation of LexA fusions of ADR1 TADIV is also described in Appendix A.
Binding assays and immunoprecipitations.
GST fusion proteins were expressed and bound to gluthatione-agarose beads as 
described in [Appendix A]. Yeast whole cell extracts were prepared from EGY188 cells 
grown to a density of 5xl07, collected by centrifugation and disrupted by bead beating in 2 
volumes of A300 buffer (20 mM HEPES. pH 7.6, ImM EDTA, 1 mM DTT, 300 mM 
potassium acetate, 1% Triton and protease inhibitors). Washed gluthatione-agarose beads 
were incubated with 1 mg of yeast whole cell extract protein in 250 ul of A300 buffer for 2 
hours at 4°C on a rocking platform. Unbound proteins were removed by four rapid (<1 
min) washes with 1 ml of A300 buffer and specifically bound proteins were resolved by 
SDS-PAGE after boiling beads directly in sample buffer. Proteins resolved by SDS-PAGE 
were transferred to PVDF membrane and analyzed by Western blotting as described 
[Draper et al., 1994]. Antibody to TAF90 was kindly provided by M. Green, antibody to 
R PB 1 subunit of RNA pol II was a gift from J. Jaehning.
Preparation of yeast extracts for immunoprecipitation were made according to 
Woontner et al., 1991, with the following modification: DTT was omitted from the final 
dialysis step.
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Immunoprecipitation.
Immunoprecipitation of triple HA 1-tagged TAF90 from yeast WCE was 
conducted in immunoprecipitation (IP) incubation and washing buffer (25 mM BCP04, pH 
7.6, 150 mM KC1, I mM NaPP„ 1 mM Na F, 5 mM MgCI2, 1 mM EDTA, 10% glycerol, 
1% Nonidet P-40 and protease inhibitors cocktail). 20 microliters of packed protein A 
agarose beads were incubated with 2|il of monoclonal 12CA5 antibody for 1 hour at 4°C 
and in 250 pi of IP incubation/wash buffer, washed once with the same buffer to remove 
excess antibody and mixed with 2 mg of yeast crude extract protein in 500 pi of IP 
incubation/wash buffer. Incubation was allowed to proceed for 2 hours at 4°C with 
constant rocking. The beads were washed 4 times with 1 ml of the same buffer to remove 
unbound proteins from the yeast extract, mixed with SDS loading buffer, boiled for 5 min. 
and separated on a 8% polyacrylamide gel prior to Western analysis.
Northern analysis.
Total yeast RNA was isolated by the hot acidic phenol method [Ausubel, 1994], 
and quantified by spectrophotometry (A,^). Approximately 40 ug of total RNA per sample 
was denatured with glyoxal and dimethyl sulfoxide and mixed with gel loading buffer 
according to [Sambrook, 1989]. Denatured RNA samples were loaded in duplicate and 
resolved on a 1.2% agarose gel, half of which was stained with ethidium bromide in 0.1 M 
ammonium acetate to verify the equality of loading, and the other half was transferred to a 
GeneScreen™ nylon membrane and hybridized to the 3’-32P-labelled ADH2 
oligonucleotide probe GTTGGTAGCCTTAACGACTGCGCTAAC [Di Mauro et al., 
1993], according to the membrane manufacturer instructions, with the following 
modification: all posthybridization washes were for 1 minute each.
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R esu lts .
TADIV specifically contacts TFIID.
We used affinity chromatography to determine if components of general 
transcription factor HD interacted with transcription activation domains of ADR1. GST 
fusions of TADI, n, m , IV and Vpu bound to glutathione-S-transferase coupled beads 
were incubated with whole cell extracts obtained from yeast strains expressing triple HA1- 
tagged TAF90, TAF25 or BRF1. As shown in Figure 10, TADIV and to a lesser extent 
TADI were capable of specifically retaining both TAF90-HA13 and TAF25-HA13, but not 
BRF1-HA13. The GST-Vpu, -TADII, -TADHI fusions and GST alone bound none of the 
tagged proteins. We subsequently examined if other components of TFUD were being 
pulled down by TADIV and I. Yeast extracts were incubated with the same GST fusions 
described above and the proteins which were retained were probed with antibodies to 
different components of the TFUD complex: TAF130, TAF90, TAF60 and TBP (Figure 
11). GST-TADIV fusion retained all of these components in amounts close to being 
stoichiometric (Figure 11, lane 4). The RPBl subunit of Pol II, however, was not retained 
by GST-TADIV. The most likely interpretation of this result is that TADIV retains the 
entire TFIID complex. TADI displayed weak binding to TAF90 and did not retain any of 
the other components of TFUD (Figure 11, lane 2), including TBP. GST-TADII displayed 
weak binding to TBP as shown previously [Appendix A] and TAF130 (Figure 11, lane 6) 
while GST-TADm did not bind any components of the TFUD complex (Figure 11, lane 
7).
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Figure 10. ADRl TADI and TADIV interact with TAF90 and TAF25.
GST fusions were induced as described [Appendix A], bound to glutathione-agarose 
beads, and incubated with yeast crude extracts from strains yEK20 containing TAF25- 
HAlj, yBY40-8’ containing TAF90-HA13 and yKG1794 containing BRF1-HA13 as 
described in “Materials and Methods”. Proteins were eluted from glutathione-agarose 
beads by boiling and separated by SDS-PAGE. They were subsequently transferred to the 
PVDF membrane and probed with 12CA5 mouse monoclonal antibody against the HA1 
epitope. One hundred (ig of GST-TAD fusion was loaded in each lane. GST-TADI 
contains residues 148-262 of ADRl; GST-TADII contains residues 262-359; GST-TADm 
contains residues 420-462; and GST-TADIV contains residues 642-704.
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Figure 11. ADRl TADIV retains TFUD from yeast crude extract.
GST fusions were induced as described [Appendix A], bound to glutathione-agarose 
beads, and incubated with yeast crude extract from strain EGY188 as described in 
“Materials and Methods”. Proteins were eluted from glutathione-agarose beads by boiling 
and separated by SDS-PAGE. Proteins were then transferred to the PVDF membrane and 
probed with the appropriate antibodies. The amount of GST fusion per lane is the same as 
described in Figure 1.
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The ability of TADIV to bind TFIID correlates with the ability of LexA- 
TADIV fusions to activate transcription.
A set of GST-ADR1 truncation derivatives of TADIV that are modeled on LexA- 
TADIV derivatives which differ in their ability to activate transcription of a LexAop-lacZ 
reporter construct was tested for their ability to retain TAF90-HA13 from yeast extracts. 
LexA-TADIV C-terminal deletions activated LexAop-lacZ reporter to different extents 
depending on the length of the ADRl moiety present in the fusion. LexA-ADRl-(642- 
704), -(642-701), and -(642-698) retained significant transcriptional activity, whereas 
shorter derivatives were less active (Table 2). As evident from Figure 12, the most active 
TADIV truncation derivatives bound TAF90-HA13 to the greatest extent, suggesting a 
functional relevance of the observed binding. Similarly, TAF130, TAF90, TAF60 and 
TBP were not retained by the transcriptionally inactive TADIV moiety represented in GST- 
TADIV-642-679 (Figure 11, lane 3).
We had shown previously that deletion of TADIV from the full length ADRl 
protein drastically reduces its ability to activate transcription of ADH2 and of a LexAop- 
lacZ reporter gene. Adding back part of TADIV which does not bind any of the TFIID 
components does not restore the ability of LexA-ADRl to activate transcription: the 6- 
galactosidase activities measured in strains expressing LexA-ADRl, LexA-ADR 1-A642- 
704 and LexA-ADRl-A675-704 are 900,50 and 105 Units/mg protein respectively. Each 
of these proteins was expressed to equivalent extents in the yeast cell (data not shown). 
This result indicates that it is the region capable of binding TFUD that is required for ADRl 
function.
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Figure 12. The ability of ADRl TADIV to interact with TAF90 
correlates with TADIV ability to activate transcription.
The effect of C-terminal deletions of LexA-TADIV on its ability to bind TAF90-HA13. 
GST-ADRl -TADIV derivatives of length as indicated in the Figure were expressed in E. 
coli. and bound to glutathione-agarose beads as described in “Materials and Methods”, 
extracts from yeast strain EGY188 were bound to the GST fusions, and the resulting 
bound proteins were analyzed by Western analysis using 12CA5 antibody directed against 
the HA1 tag, as described in Figure 1. 100 fig of every GST fusion was loaded on the gel. 
Each GST fusion was expressed at comparable levels (data not shown; [Appendix A]).B- 
galactosidase activities displayed are for LexA-TADIV derivatives in their activation of 
LexAop-lacZ and are taken from [Appendix A].
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ADRl co-im munoprecipitates with TAF90-HA13.
To address the question of in vivo association of full length ADRl with TF1ED 
we tested if ADRl can be co-immunoprecipitated with TAF90-HA13. As shown in Figure 
13, ADRl does co-immunoprecipitate with TAF90-HA13 from the yBY40-8’ strain, but 
not from strain 938-9b, that lacks HAl-tagged components of TFIID. It is worth noting 
here that growth conditions do not have an effect on this observed interaction. ADRl co- 
immunoprecipitated with TAF90-HA13 when yeast cells were grown under either 
repressing or derepressing conditions (data not shown). Although the ADRl protein in 
both 938-9b and yBY40-8’ was expressed from a multicopy vector, the pattern and nature 
of ADRl activation of ADH2 transcription remains the same when it is overexpressed 
[Denis et al., 1981, Cook et al., 1994] suggesting that the association of overexpressed 
ADRl with TAF90 represents a physiologically relevant interaction.
TAF90 is required for AD H 2  derepression.
TAFs have been implicated in co-activator function in in vitro systems by a 
number of studies [Hoey et al., 1993, Wu et al., 1996, Sauer et al., 1996]. However, 
recent results [Moqtaderi et al., 1996, Walker et al., 1996] indicate that yeast TAFs are 
dispensable for transcription of a majority of yeast genes. Using a  double shut-off system 
designed to eliminate TAF90 [Moqtaderi et al., 1996], we tested if TAF90 is required for 
ADH2 activated transcription. Yeast cells were depleted of TAF90 (Figure 14b) and then 
tested for their ability to activate the ADH2 gene upon depletion of glucose. As shown in 
Figure 14a, ADH2 derepression does not occur in a strain depleted for TAF90, but does 
occur in an isogenic control strain. In contrast, the mRNA levels for ADRl and CCR4,
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Figure 13. ADR1 co-immunoprecipitates withTAF90.
Extracts from strain yBY40-8\ containing triple HAl-tagged TAF90 and expressing ADR I 
from multicopy vector, and strain 938-9b, containing no HAl-tagged TAF and also 
expressing ADR1 from the same vector, were incubated with 12CA5 antibody directed 
against the HA1 tag, and the resulting immunoprecipitates were subjected to electrophoresis 
on a 7.5% SDS-polyacrylamide gel. ADR1 and TAF90-HA13 were detected by Western 
analysis: polyclonal antibody raised against ADR1 residues 208-231 was used for ADR1 
detection, 12CA5 antibody was used for TAF90-HA13 detection. One hundred p.g protein 
was loaded per each crude extract lane.
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Figure 14. ADH2 derepression does not occur in the absence of 
TAF90.
Total RNA from strains ZMY60 (control) and ZMY68 was prepared, separated in agarose 
gel and analyzed by Northern hybridization as described in the “Materials and Methods” 
section. Both strains were shifted to SC-Ura, 2% ethanol, 500 |iM  CuS04 after 7 hours 
incubation in SC-Ura, 4% glucose, 500 fiM CuS04. Bottom panel: Identically loaded 
duplicate gel was stained with ethidium bromide for rRNA (23S and 16S) according to 
[Sambrook, 1989]. Previous experiments have determined that rRNA serves as a useful 
standard for quantitating mRNA loadings [Cook et al., 1993, Vallari et al., 1992].
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another regulator of ADH2 expression, were essentially unaffected by depletion of TAF90 
(Figure 14a). This requirement for an intact I'FilD complex in vivo for ADH2 activated 
transcription confirms a role for TFDD in ADR 1-dependent activated transcription.
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D iscussion.
The results reported herein demonstrate an association of ADR1 with the TFI1D 
complex that appears important for ADR1 activation of ADH2 . Five lines of evidence 
suggest that ADR1 contacts 1'FllD in vivo: 1) TADIV of ADR1 binds TFIID isolated from 
yeast cmde extracts; 2) the ability of derivatives of TADIV to bind TFUD correlates with 
TADIV activation potential; 3) ADR1 co-immunoprecipitates with a known subunit of the 
TFUD complex TAF90; 4) intact TFDD is required for ADR 1-dependent activation of 
ADH2 in vivo, as depletion of the yeast cell of TAF90 prevents ADH2 derepression; and 
5) deletion of TADIV from ADR1 severely compromises ADR1 function. This suggests a 
model where ADR1 either aids recruitment of TFIID to the promoter, induces structural 
reconfiguration of TFIID, or stimulates both processes, thereby allowing for transcription 
to occur. However, our attempts to show that TADIV contacts TAF90 directly have been 
unsuccessful to date (data not shown). There are several possible explanations for how 
depletion of TAF90 could affect ADH2 without ADR1 contacting TAF90 directly. 
Depletion of TAF90 may result in the release of other TAFs from the TFUD complex and 
one of those TAFs may be the one(s) that directly contact TADIV. Studies of the human 
yTAF90 homolog hTAFlOO reveal that hTAFlOO strongly interacts with a number of other 
TAFs [Tao et al., 1997 , Dubrovskaya et al., 1996] and this interaction could be necessary 
to keep these other TAFs in the TFIID complex. Alternatively, an as yet unidentified co- 
factor may mediate the interaction of TADIV with TAF90. It should be noted here that our 
previous results [Appendix A] indicate that TADIV does not contact TBP directly. It is also 
possible that TAF90 depletion may impose a new rate-limiting step on ADH2 derepression 
unrelated to the ADR 1-dependent recruitment of TFIID. The latter possibility seems quite 
unlikely though since TAF90 is dispensable for activated transcription of many yeast 
genes.
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We found that ADR1 coimmunoprecipitates with TAF90 under both repressing 
and derepressing conditions. It needs to be taken into account, though, that in the strain in 
which the immunoprecipitation was done ADR1 was overexpressed from a multicopy 
vector and that this overexpression allowed partial derepression of the ADH2 gene on 
glucose to approximately 10% of the fully derepressed level on ethanol. These results 
suggest that even in the presence of glucose, ADR1 can still make appropriate contacts at 
the ADH2 promoter. It is possible that glucose repression affects not the ADR I-TFIID 
interaction, but some other aspect of ADR 1-dependent ADH2 promoter function. One such 
aspect could be ADR 1-dependent chromatin remodeling that occurs only under 
derepressing conditions [Verdone et al., 1996]. On the other hand, glucose may negatively 
affect ADH2 promoter function at least in part not through the ADR1, but via an ADR1- 
independent mechanism. The observation that LexA-ADRl fusion protein functions as a 
potent activator outside the ADH2 promoter context in the presence of glucose supports 
this notion [Cook et al., 1994a].
We had shown previously [Appendix A] that ADR1 TADs directly contact GCN5 
and TFUB and suggested that there should be additional targets for ADR1 activation 
domains. TFIID now seems to be a very likely target for ADR1 function. It should be 
noted, that TADIV of ADR1 is capable of strong binding of GCN5 and TFIID and that 
sequence determinants important for both interactions are located in residues 695-704 of 
TADIV.
The most widely accepted model describing how DNA-binding transcriptional 
activators function is that these proteins recmit components of the general transcription 
machinery to the promoter accelerating or allowing the formation of preinitiation complex 
(PIC) or stabilizing the PIC at the promoter [Ptashne, 1997]. The requirement imposed by 
this model on transcriptional activators is that they should physically interact with some of 
the general transcription factors either directly or via intermediate factors, which are called 
coactivators. Our results indicate that there may be several targets for ADR1 TADIV. A
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number of targets for activation domains of various Drosophila, mammalian and yeast 
activators has been identified to date. They include a large number of core transcription 
factors, such as TFilB, TFIID, TFHF, TFTIA, TFLLH, RNA Pol n, IFlLb, etc. [Ptashne, 
1997, Zawel, 1995, Burley, 1996 and references therein], as well as proteins dispensable 
for basal transcription in vitro (co-activators): for instance, CBP, SRC-1, or components 
of ADA complex [Heery et al., 1997, Bariev et al., 1995]. Some of the co-activators have 
histone acetyltransferase (HAT) activity, and the mechanism had been proposed [Grant et 
al., 1997] by which targeted recruitment of HATs to the promoters by activators results in 
removal or rearrangement of repressive nucleosomes, thus allowing formation of the 
initiation complex. In this regard, one of the Drosophila TAFs, dTAF 250, posesses HAT 
activity, and this HAT activity is conserved in its yeast homolog, yTAF130 [Bai et al., 
1997; Gopal and Weil, unpublished observation]. Recently, the direct role of acetylation in 
modification of activity of some transcription factors had been suggested [Gu et al., 1997, 
Bannister et al., 1997]. Regardless of what the exact mechanism of the observed effect is, 
TAFs do seem to be required for ADH2 derepression. This observation distinguishes 
ADH2 from many tested yeast genes, whose basal and activated transcription does not 
seem to be dependent on TAFs [Moqtaderi et al., 1996, Walker et al., 1996],
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General Discussion.
RNA polymerase II transcription is a very complex process and is influenced by a 
variety of regulatory stimuli. The mechanism of transduction of these diverse stimuli to the 
general transcription machinery involves post translational modifications of transcription 
factors as well as changes in their subcellular localization. The end result of the action of a 
given signal is a change in transcription rate of one or more genes. The aim of the above 
described research was to understand the mechanism of the ADR 1-mediated increase in the 
transcription rate of the ADH2 gene in response to glucose. In particular the focus of this 
research was understanding how the binding of the ADR1 to its cognate DNA recognition 
sequence brings about the activation of the downstream gene.
It was found that the activation domains of ADR1 are capable of physically 
contacting the components of general transcriptional machinery, namely TFTLB and TFIID, 
as well as the components of the ADA2 co-activator complex. Additionally, functional 
relevance of the observed physical interactions was supported by genetic methods. Point 
mutations in TFHB that reduced its in vitro binding to ADR1 TADI decreased ADH2 
derepression in vivo. Targeted degradation of the TAF90 component of the TFIID 
abolished ADH2 derepression. Deletion of ada.2 or gcn5 also strongly affected ADRl- 
mediated transcription.
Interestingly, the extent of the effect of ada.2 or gcnS deletions or of a point 
mutation in the TFHB on ADH2 transcription was much less than the effect of TAF90 
targeted degradation, even though the pattern of binding of these proteins to ADR1 appears 
to be similar. The possible reason for this may be that the TFUD binding step is strongly 
inhibited at the ADH2 promoter and is the rate limiting step at this promoter in the absence 
of ADR1. The recruitment of the TFIID to the ADH2 promoter by ADR1 requires TAF90,
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and after TFUD is recruited, other steps, such as TFDB entry into the preinitiation 
complex, become rate limiting. Even though these steps also can be influenced by ADR I, 
the “intrinsic” rate of TFllB entry into the complex is higher than that of the TFUD. This 
hypothetically higher rate ofThilB recruitment without ADR1 participation allows 
substantial transcription to occur even when ADRl-TFHB interaction is disrupted.
The disruption of the ADA2 complex may have effects that are less severe than 
TFUD has on ADH2 transcription due to the partial redundancy of function. Recent data 
[Brownell et al., 1996] indicate that the function of the ADA2 complex is to relieve 
repressive chromatin structure by histone acetylation. Yeast TFUD also contains a histone 
acetyltransferase (HAT) activity, namely the TAF130 component of TFUD is a histone 
acetyltransferase [Gopal and Weil, unpublished observations]. So, even though ADA2 
function is required for maximal activity of the promoter, it seems likely that repressive 
nucleosomes can still be modified by some other HAT, one plausible example being 
TAF130. An alternative possibility is that the activation of the ADH2 may occur without 
the ADA2 complex function simply because this function is not crucial for this particular 
promoter.
Interestingly, deletions of the spt3 or spt7 gene apparently results in a severe 
defect in ADH2 derepression [V. Badarinarayana, C. L. Denis, pers. commun]. SPT3 had 
been shown to associate with TBP [Eisenmann et al., 1992], and both SPT3 and SPT7 
were found to be a part of the SAGA (Spt/Ada/Gcn5) complex [Grant et al., 1997]. One 
possible model which may explain why some components of SAGA have a stronger effect 
on ADH2 transcription than others is that the main function of SAGA at the ADH2 
promoter may be not to modify chromatin (this function would be completely abolished by 
the GCN5 disruption) but to function as an adaptor between ADR1 and TFIID. The SPT3 
and SPT7 components of SAGA may be crucial for this adaptor function (Figure 15).
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Figure 15. Mechanism o f ADR1 function at the ADH2  promoter
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T h e y e a st  tran scrip tion a l ac tiv a to r  A D R lt w h ic h  is  
req u ired  for ADS2 an d  peroxisom al g e n e  ex p ress io n , 
co n ta in s  fou r sep a ra b le  and p artia lly  r ed u n d a n t a c tiv a ­
tio n  d om ain s (TADs). M utations in  ADA2 o r  GCV5, e n ­
co d in g  co m p o n en ts  o f  th e  ADA co a ctiv a to r  co m p lex  in ­
vo lved  in  h is to n e  acety la tion , sev e r e ly  red u ced  LexA- 
ADR1-TAD a c tiv a tio n  o f  a LexA-lacZ rep o rter  gen e . 
Sim ilarly , th e  a b ility  o f  th e w ild -typ e ADRl g e n e  to  a c ­
t iv a te  a n  AD£T2-driven prom oter w as co m p ro m ised  in  
s tra in s  d e le te d  fo r  ADA2 o r  GCS5. In  co n tra st, d e fe c ts  In 
o th er  g en era l tran scrip tion  cofactors su c h  a s  CCR4, 
CAFI/PO P2, an d  SNF/SWT d isp layed  m u ch  le s s  o r  no  
e ffec t o n  LexA-ADRl-TAD activa tion . U sin g  a n  in vitro 
p ro te in  b in d in g  a ssa y , ADA2 and  GCN5 w e re  fou n d  to  
sp ec if ica lly  co n ta c t  in d iv id u al A D R l TADs. ADA2 co u ld  
b in d  TAD II, a n d  GCN5 ph ysica lly  in tera c ted  w ith  a ll 
fou r TADs. B o th  T A D s I and  IV w ere  a lso  sh o w n  to  m ak e  
sp e c if ic  co n ta c ts  to  th e  C-term inal seg m en t o f  T FIIB . In 
co n tra st, no s ig n if ica n t b in ding to  T BP w a s  ob serv ed . 
TAD rV d e le tio n  a n a ly s is  in d ica ted  th a t its  a b il ity  to  
b in d  GCN5 an d  T F u B  w as d irectly  co rre la te d  w ith  its  
a b ility  to  a c tiv a te  tran scrip tion  in vivo. A D R l T A D s a p ­
p ear  to m ake sev e r a l con tacts, w h ich  m ay h e lp  ex p la in  
both  th e ir  p a rtia l red und ancy an d  th e ir  v a r y in g  re­
q u irem en ts  a t d if fe re n t prom oters. T he c o n ta c t  to  and  
d ep en d en ce  o n  GCN5, a  h iston e a cety ltra n sfera se , s u g ­
g e s ts  th a t  rea rra n g em en t o f n u c le o so m e s  m a y  b e  
o n e  im p o rta n t m ea n s  b y  w h ich  A D R l a c t iv a te s  
tra n scr ip tio n .
In Saccharomyces cerevisiae, the transcriptional activator 
ADR! is required for expression of the glucose-repressible al­
cohol dehydrogenase gene tADH2) under nonfermentative con­
ditions (1). It also regulates genes required in glycerol metab­
olism (2, 3) and peroxisome function and biogenesis (4, 5). 
ADRl is a zinc finger, DNA-oinding protein that is 153 kDa in  
size (6, 7). Its regulation of ADH2 under nonfermentative 
growth conditions occurs by binding to U A Sl, a palindromic 
site, located 110 bp1 upstream of the ADH2 TATAA sequence
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This p a p e r  U a v a ila b le  o n  l in e  a t
(7). Similar U A Sl elements are located upstream o f other genes 
that ADRl controls (4. 8). Three regions o f ADRl have been 
identified that are required for its efficient activation oZADHZ 
transcription: transcription activation domain 'TAD) I 76- 
172), TAD II f263-357). and TAD III (359-509X 2. 9 .1 0 . 11*. A 
fourth region <642-1323) has been implicated for efficient per­
oxisomal gene expression (5). The presence o f four transactiva- 
tion regions suggests that ADRl may make multiple protein 
contacts to transcriptional cofactors and/or core transcriptional 
components. The observation that TADs H and HI are func­
tionally redundant (9) suggests that some o f these contacts may 
be made to the same protein.
There are a number o f potential targets for ADRl activation 
domains. Core transcriptional components including TBP. 
TFIIB, TFllF . TFHE, and TAFs have been implicated in  mam­
m alians system  as being direct contacts for transcriptional 
activators i 12). In yeast, the GAL4 activation domain has been 
shown to bind TBP but not TFIIB in vitro '13). In addition to 
these core transcriptional factors, other cofactors or coacriva- 
tors may mediate the action o f activators. The ADA2 complex is 
one such coactivator complex. These proteins have been shown 
to bind activators like VP16 and GCN4 (14. 15) and to be 
required for maximal transcriptional activity of several yeast 
activators (16). However, some yeast activators like HAP4 and 
GAL4 (16 ,17) are slightly affected or not affected by defects »n 
the ADA2 complex. Because the ADAS complex has been also 
been shown to bind TBP (14), it has been suggested that the 
ADA2 complex acts as a direct mediator between activators and 
core factors. Recent evidence indicates that GCNo is a histone 
acetyltransferase '18). Activator recruitment o f the ADA2 com­
plex may result, therefore, in histone acetylation that would 
help relieve a repressive chromatin structure.
Genetic studies have implicated several general transcrip­
tional factors as possibly mediating A D R l activator function. 
The CCR4 and CAF1/POP2 proteins, components o f a muiti- 
subunit transcriptional regulatory complex, are required for 
proper expression of a number of yeast genes including ADH2 
(19-22). In previous studies we have analyzed the dependence 
o f A D R l TADs on the CCR4 and CAFl cofactors, but ccr4 and 
cafl defects generally had only 2-3-fold effects on A DRl TAD 
function (22, 23). Moreover, ccr4 and cafl defects can affect 
ADH2 expression under conditions when A D R l is inactive > 19. 
22). The SNF/SWI factors involved in nudeosomal remodeling 
(24) are also known to be important to ADH2 derepression 
(25-27). Consistent with the role of the SNF/SWI factors in 
ADH2 expression are the presence o f two repressing nucleo­
som es at the ADH2 promoter that are removed in an ADRl- 
dependent manner during ADH2 derepression (28). N either of 
the repressing nucleosomes in the ADH2 promoter occupies the
domain: GST, glutathione 5-cnuisferase; PAGE, polyacrylamide gel 
electrophoresis; KAc, potassium acetate.
h ttp : / /w w w - jb c jC in fo rd .e d u / ib c /  32359
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U A Si site to which ADR1 binds (28), which may explain the 
limited e je c ts  o f snflswi mutations on ADH2 derepression
(25, 27).
In this paper we continue our investigation into the factors 
required for A DRl function. We report that mutations inADA2 
and GCN5 severely compromise the ability o f ADRl TADs to 
activate gene expression in uiuo. In addition, we demonstrate 
that there is  physical interaction between ADA2 and GCNo 
and the A DRl TADs in vitro. TAD IV binding to GCK5 was 
shown to directly correlate with TAD IV activation function. 
TADs I and rv were aiso shown to make specific contacts to 
TFIIB but not to TBP. These results suggest that ADRl TADs 
activate gene expression in yeast through direct physical con* 
tacts with multiple proteins.
EXPERIMENTAL PROCEDURES 
Yeast Strains
Yeast strains are listed in Table L Strain EGYI88 was used for 
transformation with plasmids expressing LexA-ADRl fusion proteins. 
The ada2::(jRA3 and gcn3::URA3 disruptions in strain PSY316 were a 
gut from L Guarante, and strains CY26 and CY57 were provided by C. 
Peterson.
Plasmid Constructions
LexA-ADRl Fusions— Ail LexA-contaming plasmids encoded full* 
length LexA-1-202) except for LexA-ADRl-( 1-220). which contained 
only the DMA binding domain of LexA < residues 1-871. The LexA fusion 
proteins were expressed from an ADHI promoter and were expressed in 
yeast on a 2 t* plasmid containing die selectable marker CRA3 >9). 
Plasmids containing LexA-ADRl-(1-1323) (full-length), LexA-ADRl- 
vl-220)-TAD I. and ADRl-'262~359)-TAD [I have been previously de­
scribed (9). LexA-ADRl-<420-462)-TAD III was constructed following 
polymerase chain reaction using oligonucleotides designed Co generate 
.Vcol and Xhol sites at the ends of the 420-462 fragment of ADRl 
(oligonucleotides: S'-GTCATGCCATGGATCCTGATTTCGTCGAT-S*
and 5*-GCGTACTCGAGAAGmTGACGTGGCGOTAG-3*). The result­
ant ADRl polymerase chain reaction product after cleavage with iVcoI 
and Xhol was ligated into the iVcoI-XhoI sites of plasmid LexA-202-5 (9) 
to generate LexA-ADRl-t420-462). LexA-ADRl4642-704)-TAD IV and 
its deletion derivatives were derived from plasmid LexA-ADRl-(642- 
1323) (9) by selectingfor LexA-ADRl 4642-1323) derivatives that could 
activate the LexAop-LEU2 reporter in strain EGY188- All Leu2* pro­
te trophs analyzed were the result of alterations in the amino add 
region 672-704 of ADRl that created truncated LexA-ADRl4642-704) 
derivative proteins. Each of these proteins was expressed to a compa­
rable extent as analyzed by Western analysis. Sequencing of each of 
these resultant plasmids revealed stop codons in the DMA sequence 
that were in agreement with the relative size of each of the LexA-ADRl- 
(642-704) protein derivatives.
GST-ADR1 Fusions—The construction of GST-ADRl-Cl-262)-TAD I 
was conducted by removing residues 1-262 from pJClOO (29) with iVcol 
and . 'Em /I I and ligating into pG EM-5 IT - }  cut with Ncol and EeoRV. The 
resultant plasmid was then digested with Ncol and Sail and ligated 
into .Vcol and Xhol sites of pGEX-KG (30) to create GST-ADR141-262). 
GST-ADRl-263-359)-TAD II was constructed by inserting a BamHI- 
S a il fragment of LexA-AD Rl -TAD R into 3cm HI-Sail sites of pGEX-
Genotype
\L\Ta ura3—52 hi/3 trpl LexAop-LEL'2
Seme as EGY188 except gcno • • URA3
MATa ode2-lQl his3-3200 Ieu2-3J12 lys2 un3S2
Same as PSY316 except ada2 URA3
Same as PSY316 exceptgcno--URA3
MATa ura3-52 fus3-320O trpl-<11 ieu2-\2 lys2-901a ade2~I0!o
Same as CY26 except sun2 : ■ HIS3
MATa ura3 his3 Uu2 trpl adhl-l I
Same as 612—Id except ada2 '■' URA3
Same as 612-ld except gcno ■ ■ URA3
Same as 612-ld except cafS : LEV2
MATa urej kis3 leu2 trpl sptlO- TRPl adhl-ll
MATa adhl-ll adrl-l ADRl-S'-TRPl ura3 leu2 his3 up I
MATa urtx3 his3 trpl adhl—ll  adrl—lADRl-TRPl
KG. GST-ADR14420-462J-TAD III was constructed by inserting a 
Xcol-HLndUl fragment of LexA-ADRl-TAD HI into the Ncoi-HindUI 
sites of pGEX-KG. In the construction of GST-ADRl-TAD IV’-*642-704), 
a DNA fragment from. LexA-ADRl-TAD IV-<642-704) was synthesized 
by polymerase chain reaction with oligonucleotides 5 * -GO ITC AC CAT - 
TGAAGGGC-3' and 5'-CCGAATTCACAAGATTTGATAGTGCTCG-3' 
designed to create Smal-EcoRl restriction sites at the ends. This frag­
ment was ligated in 5moI-£coRI sites of pGEX-KG that had been 
precut with BamHI, blunt ended with the large subunit of Esehenchia 
coli DNA polymerase (Klenowj, and religated. For all other GST-ADRl- 
TAD IV truncations, a SmnI-£coRI fragment from the LexA-ADRl - 
TAD IV truncations was inserted into SmcI-£coRI sites of pGEX-KG 
whose BamHl site had been filled in with Klenow to create the proper 
reading frame. GST-Vpu contains the hydrophilic segment of the HIV I 
protein Vpu '.residues 33-81) and was a gift of B. Kemp (St Vincent's 
Institute of Medical Research. Melbourne. Australia;. GST-CAFl and 
GST-CCR4 were provided by J. Meegan and S. Fontaine (University of 
New Hampshire. Durham, NH). respectively.
Transformations, Enzyme Assays, and Growth Conditions
All yeast transformations were conducted by using the lithium ace- 
eate method '31). ADH II and d-galactosidase enzyme assays were 
conducted as described (9). Conditions for growth of cultures on mini­
mal medium lacking uracil and histidine or YEP medium containing 
either 8% glucose, 3% ethanol or 2% ethanol. 2% glycerol have been 
described elsewhere (9*.
In Vitro Binding .Assay
GST fusion proteins were expressed and bound to glutathione-aga- 
rose beads < Sigma; in binding buffer < 1 * phosphate-buffered saline. 
Tnton). Beads were washed 4 times with binding buffer and then 
incubated for 60 min at 4 *C in A300 buffer (20 mM HEPES. pH 7.6. 1 
mM EDTA. 1 mM dithiothreitol. 20% glycerol. 300 mM potassium acetate 
{KAc;, 1% Triton; containing I mg'mi E. coli extract and 40-200 r.g of 
[“ SImetiuomne-labeled in vitro translated proteins. In vitro transla­
tion of T7 fusion proteins was carried out by using the TNT-coupied 
transcription translation system (Promega). Unbound proteins were 
removed by four washes with A30O buffer, and specifically bound pro­
teins were analyzed by SDS-PAGS after elution with 50 mM reduced 
glutathione in 50 mM Iris, pH 8.0, or by boding beads directly in sample 
buffer. High salt washes of radiolabeled proteins bound to GST fusions 
were conducted as described above except that A300 buffer was changed 
to the appropriate KAc concentration (600. 900. or 1200 mM). The 
T7-GCN5. -ADA2, and -ADA3 plasmids were gifts of L  Guarente (MIT). 
T7-TFUB was provided by M. Hampsey (University of New Hamp­
shire). T7-TBP was <t gift of S. Johnston (University of Texas South­
western Medical Center), and T7-N-TFHB and T7-C-TFIIB were pro­
vided by R. Pollock (Arias Pharmaceuticals).
Deletion of Residues 642—704 of ADRl at Its Chromosomal Locus
The ADRl moiety in pBR322-4llB (32) was cut with BgDl *'bp 
4-1,923) and BsrBI (bp -2,119). and the overhangs were filled in with 
Klenow and re ligated with 74 DNA ligaae. The resultant plasmid was 
digested with Sael (bp r  1,713) and BomKI (bp -3.200). and the 1.5-kb 
ADRl fragment containing the deletion was ligated to pCDIO *9} pre­
viously treated with Sac I and 3am HI. To improve the efficiency of 
integration, the Sam HI fragment of pCDIO (bp 3,200-3.609) was added 
back to the pCDIO plasmid, which contained the BgHl-BstBl deletion.
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A D R l Contacts ADA2, GCNot and TFIIB 32361
T a b l e  U,
The effect of ada2, gcnS, and snf2 deletions on the ability of LexA-ADRl fusions to activate a LexA-lacZ reporter 
3-Gaiatxostdase activities (units/mgj represent averages of at least three separate transformants measured in isogenic strains PSY31S 'wild 
type;. PSY3l6-uda2 <ada2), and GMY26 {gcnSi and the isogenic strains CY26 (SNF2), and CY5? snj2) using the LexA-lacZ 1S40 reporter gene os 
previously described (9). The 1840 reporter plasmid contains a single LexA operator site upstream of the GAL I-lacZ promoter. LexA-ADRl fusions 
are described under "Experimental Procedures." TADs I and II were defined as activation domains previously (9.10); TAD n i  previously localized 
to residues 359-506 (9) was more precisely located to 420-462 (J. Saario and T. Young, personal communication); and TAD IV was denned as 
shown in Fig. 3 and Table V. Strains were grown on minimal medium lac in g  uracil and histidine and supplemented with 8% glucose as previously 
described >9). LexA fusions were expressed to comparable levels as determined by Western analysis. The LexA-ADRl fusion proteins were 
approximately 50-fold more abundant than single copy ADRl. S.E. values were less'thaa 20% in each case.
L«xA fasten 3-GalactostdaM activity
ada2 g e n s SST2
ADRl-* 1-1323) /full-length} 
ADR1-U-22QI-TAD I 

































The resulting construct was cut with 5/taBl and transformed into strain 
500-16 to site-spedficaily integrate at the adrl-I locus. Identification of 
single integrants and their subsequent analysis were conducted as 
described previously '33).
RESULTS
The ADA2 Complex Is Required for ADRl Activation of Tran­
scription—ADRl contains three separate transcription activa­
tion domains, and a fourth activation region has been impli­
cated :n residues 642-1323 (5, 9). TAD IV was subsequently  
more precisely localized to residues 642-704 (see below). In 
order to identify the factors through which the four individual 
A D R l TADs act, the effect o f deleting different general tran­
scription cofactors or adaptors on LexA-ADRl-TAD transacd- 
vadon has been analyzed.
Deletion of the ADA2 or GC.Vo gene dramatically reduced 
the ability o f LexA-ADRl (full-length) to activate the LexA-lacZ 
reporter gene (Table II). Moreover, the activation function of 
each LexA-ADRl-TAD was shown to be highly dependent on 
functional ADA2 complex components (Table CD. The expres­
sion o f the LexA-protein fusions was unaffected by deletions in 
ADA2 or GCNS as analyzed by Western analysis (data not 
shown;. An ada2 or gcrtS deletion does not uniformly affect all 
LexA transactivators (16. 17), and its reduction o f A D R l acti­
vation ability (20-50-fold effects) appeared to be one o f the 
most severe o f the several activators previously tested (17, 34}. 
The observation that both an ada2 and a gcnS deletion affected 
LexA-ADRl-TAD function is in agreement with previous re­
sults demonstrating that inactivation of any component o f the 
ADA2 complex reduces the function of the complex (17, 35). In 
contrast to these results, the deletion of the SNF2/SWI2 gene, 
which is known to severely reduce the activity o f GAL4 and 
other LexA transactivators (36), displayed little or no effect on 
AD R l TAD function (Table II). Similarly, deletion o f the SNF5 
and SWIl genes, two other components o f the SNF/SWT com­
plex, resulted in little or no diminution o f ADRl TAD function  
(data not shown). In addition, we have previously shown that 
mutation o f either CCR4 or CAFl, two components o f a  m ulti­
subunit transcription complex required for maximal ADH2 ex­
pression, had generally only 2-3-fold effects on LexA-ADRl- 
TAD activation o f a LexA-lacZ reporter (22. 23).
In order to verify the physiological relevance o f the require­
m ent o f the ADA2 complex for ADRl activation, we exam ined  
whether the activation ability o f the wild-type full-length  
ADRl protein at its normal cellular concentration w as also  
compromised. We found that deletion of the ADA2 or GCNS 
gene dramatically reduced the ability of ADRl to activate an 
ADH2-lacZ reporter under derepressed growth conditions (Ta­
ble III). The derepression o f the ADH2-lacZ reporter gene has
been shown previously to be strictly dependent on ADRl f7 \  
and ADH2-lacZ contains all of the promoter sequences neces­
sary for complete derepression of ADH2 (37). In contrast, an 
ada.2 or gcn5 deletion had at most 2-fold effects on the similar 
CYCl-lacZ reporter gene, which is under the control of the 
H A Pl and HAP2/3/4 activators (Table HD. Relatedly, the 
LexA-HAP4 transactivation ability is not affected by ada2 or 
gcno deletions (16, 17).
We subsequently analyzed the effect o f ada2 and gcno de­
fects at the wild-type ADH2 promoter. ADH2 expression was 
reduced 2.5-fold by an ada2 deletion under ethanol growth 
conditions (Table IVV Similarly, the ability o f an ADRlc ailele 
to bypass glucose repression and allow increased ADH2 expres­
sion w as reduced about 3-fold by an ada2 defect (Tabic IV). The 
ada2 allele, in contrast, had no effect on spflO-enhanced ADH2 
expression under glucose-repressed conditions, which occurs in 
an ADRl-independent manner (Table IV) (19). A gcno ailele 
also reduced die ability o f the ADH2 gene to derepress / Table 
IV). These results indicate that the ADA2 complex is required 
for ADRl-dependent activation o f transcription in different 
promoter contexts.
Components of the ADA2 Complex Physically Interact with 
Each of the TADs ofADRl—Siti ce the activation ability of the 
ADRl TADs was strongly ADA2 complex-dependent, we tested 
i f  this dependence was the result o f ADA2. GCN5. and ADA3 
proteins making direct contacts w ith ADRl TADs. GST fusions 
to individual ADRl TADs were constructed (Fig. LA), and their 
ability to bind to [^Slmethionine-labeleri in vitro translated 
ADA2, ADA3, and GCNS proteins (Fig. Lfi) w as examined 'Fig. 
lO -  As shown in Fig. 1C, second row, GST-ADRl-TAD II could 
bind the ADA2 protein. ADA2 did not bind control proteins 
GST and GST-Vpu, nor did it display significantly increased 
binding to GST-ADRl-TAD I, III, or IV (Fig. lO . In control 
experiments, in vitro translated luciferase w as incubated with 
each o f the GST-ADRl-TADs and GST, and no binding to any 
of these fusions was observed (Fig. lO .  In vitro translated 
ADA3 did not bind to any o f the four GST-ADRl-TADs 'Fig. 1C, 
third row). In contrast, in vitro translated GCN5, while inca­
pable o f binding to GST alone, did bind to all four GST-ADRl- 
TADs (bottom row). GCN5, however, did not display binding to 
other GST-fusions such as GST-CAFl or GST-Vpu (bottom 
row). For ADA2 binding to TAD II and GCNS binding to each of 
the TADs, generally about 1-5% of the input radioactivity was 
retained by the GST-TADs (data not shown/.
The stability of binding o f ADA2 and GCN5 to ADRl TADs 
was further tested by determining the effect o f  increasing salt 
concentrations on each of these interactions. As shown in Fig. 
2, the binding between GST-ADRl-TAD H and ADA2 was
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Table m
Effect of the ada2 and gcnS alleles on ADRl activation of the ADH2-lacZ gene 
3-Gala ctosiriase activities (units/mg) represent the average of at least three separate transformants measured in the isogeme strains PSY316 
(wild type>, PSY316-ada2 (ada2), and the strain GMY26 fgen5) as described (9). Each of these strains earned either the ADCY4 reporter piassud 
'ADH2-iacZ) or the LG6S9Z (CYCl-lacZ) reporter (7). ADCY4 and LG699Z are identical except for the upstream sequences controlling the CYC I 
TATA region in front of the LacZ gene. Strains were grown in minimal medium lacking uracil and containing 2% each of glycerol and ethanol DR) 
or 8% glucose >Ri. S.E. values were less than 15%. ND, not done.




ADH2-lacZ PSY315 1.8 290 1.5 6.3 ND 0.45
CYCl’lacZ PSY316 12 640 2.5 290 ND 430
Table EV
The effect of ada2 and gcnS alleles on ADH2 expression 
ADH tl enzyme activities were conducted as described under “Exper­
imental Procedures.* Strains were grown either on 8% glucose (R) or 3% 
ethanol (DR). Wild type, strain 612-ld; ada2, isogenic to 612-ld except 
ada2: CRA3; gcno, segregonts from croas-EGYl88-gl (gcnS) and 612- 
ld-6a; adrl, data taken from Re£ 9. ADRl-5* ada2, and ADRl-5* 
segregants were from crcss-612-Ld-al(tida2) and 787-6b (ADRl-o^ r, 
sptIO ada2, and sptlQ segregants were from cross-612-ld-al <ada2) 
and l005-2-3b (sptIO). For the wild-type segregants from cross- 
EGYlSfi-gl and 612-ld-6a. ADH Q enzyme activities ranged from 2000 
to 2700 milliunitsfxng. ADH II activities were the average of at least 
four separate determinations for individual strains or the average of at 











ADR 1-5* ada2 64 ND
sptIO 85 ND
sptIO ada2 110 ND
stable to salt concentrations up to 1.2 m KAc. Similarly, the 
binding between GST-ADRl-TAD IV and GCN'5 was relatively  
insensitive to increasing salt concentrations (Fig. 2). GCNS 
binding to A D R i TADs 1 .11, and III was also stable at high salt 
concentrations (Fig. 2). These results suggest that the depend­
ence o f A D R l TAD activation on the ADA2 complex was the 
result o f specific ADRl TAD interactions with GCN5 and 
ADA2.
Binding of GCNS to ADRI TAD IV Deletion Derivatives Cor­
relates with Their Ability to Activate Transcription.—Deletion  
analysis o f ADRI suggested a fourth possible activation domain 
in the C-terminal 642-1323 region (9). We have subsequently 
shown th at LexA-ADRl-<642-704) is capable of activating  
transcription o f a LexA-lacZ reporter plasmid (Table II and Fig. 
3A). T his region was confirmed as important to full-length 
ADRI function, since deletion o f residues 642-704 reduced 
LexA-ADRl activation o f a LexA-lacZ reporter gene by 16-fold 
(Table V) without affecting LexA-ADRl abundance (data not 
shown). Moreover, deletion of TAD IV from the wild-type ADRI 
at its chromosomal locus reduced ADRI ability to activate 
ADH2 by 20-fold (Table V). TAD rV has also been shown to be 
absolutely required for peroxisomal function in the utilization  
of oleate (5). Because TAD rV appears to be especially impor­
tant for ADRI function, we characterized TAD IV further as to 
its regions important for activation and binding to GCNS.
C-terminal deletions of LexA-TAD IV were assayed for their  
ability to activate a LexA-lacZ reporter gene (Fig. 3A). All 
deletion derivatives were expressed to comparable extents In 
yeast (data not shown), indicating that differences in protein 
stability were not the cause of the differences in activity. LexA- 
ADRl-<642-704), -(642-701), and 4642-698) retained signifi­
cant transcriptional activity, whereas LexA-ADRl*<642-694> 
and smaller derivatives were less active.
To determine i f  these differences in LexA-TAD IV derivative 
activation abilities were a potential consequence of their ability 
to interact with GCN5, GST fusion proteins o f the TAD IV 
deletion derivatives were constructed, and their ability to bind 
with radiolabeled GCN5 was analyzed. All o f the GST-TAD rV 
derivatives were expressed to comparable extents (Fig. 3B. 
bottom row). The ADRI-(642-704), AD R l 4642-701), and 
ADRl-<642-698) moieties, which had the greatest activation 
abilities (Fig. 3A), displayed the strongest binding to GCN5 
(Fig. 33, top row). The remaining derivatives displayed reduced 
binding to GCN5 and reduced ability to activate. These data 
show that the activation strength of ADRI TAD IV derivatives 
correlates directly with that o f their binding to GCN5 (see 
Fig. 3A).
TADs I and IV of ADRI Bind Specifically to TFIIB —The 
observation that a gcno or ada2 disruption resulted in only 
partial blockage of ADRI activation o f ADH2 (Table IV) sug­
gested that ADRI was interacting with factors in addition to 
the ADA2 complex. Because it is known that transcriptional 
activators can make contacts to several different cofactors and 
core transcriptional components, we analyzed further whether 
ADRI TADs could bind the transcriptional factor TFIIB. Incu­
bation o f in vitro translated yeast TFIIB with GST-ADRl-TAD 
fusions demonstrated that TAD I and to a lesser extent TAD IV 
could retain TFTIB (Fig. 4). In vitro translated TFIIB. in con­
trast, did not display significant binding to GST alone, GST- 
Vpu, GST-TAD II, or GST-TAD IH (Fig. 4). TFIIB was able to 
bind about 5-fold better to GST-TAD II than to GST alone but 
only about 2-fold better than to GST-Vpu, suggesting that this 
interaction between TAD II and TFIIB may not be significant. 
The binding o f TFIIB to TADs I and IV was also stable to high 
salt washes (1.2 m KAc) (data not shown). The region of TAD EV’ 
that was capable o f binding TFIIB was analyzed using the 
series o f GST-TAD IV variants described above. Deletions of 
TAD IV that reduced its activation function (Fig. 3A) similarly 
reduced its binding to tF IIB  (Fig. 3B). As shown with GCNS 
binding to these TAD IV deletion variants, the correlation 
between TAD IV activation ability and binding to TFIIB was 
nearly exact (Fig. 3A).
The region o f TFIIB that interacted with TAD I and TAD rV 
was localized using the in vitro binding assay in  order to 
further examine the specificity o f this interaction. The C-ter- 
minal half o f TFIIB (residues 135-345; was found to retain the 
ability to bind to both TADs I and IV, whereas the N-terminal 
segm ent o f TFIIB (residues 1-134) did not bind GST-TADs I or 
IV (Fig. 5). In contrast to TFIIB, TBP displayed little or no 
increased binding to GST-ADRl-TADs I or IV as compared 
with the control GST-Vpu (Fig. 4). TBP also did not bind TAD 
HI and interacted with TAD H only about 2-foid better than the 
GST-Vpu control. These data suggest that TFIIB may be an 
additional factor through which ADRI acts.
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BINDING
FlC. I. Binding of ADRI TADs to ADA2 and GCNS. A, Coomaa- 
sustained GST-TAD fusions. GST fusions were induced as described 
;3Q). bound to glutathione-agaroae beads, and eluted from glutathione- 
agamse beads by boiling and separation by SDS-PAGE. Fifty Mg of 
GST-TAD fusion is represented in each lane. GST-TAD 1 contains 
residues 1-262 of ADRI; GST-TAD H contains residues 262-359; GST- 
TAD HI contains residues 420-462; and GST-TAD IV<r»nrains residues 
642-701. B, in vitro translated proteins. T7 fusion proteins were trans­
lated in uitro with ["Slmethiomne as described under “Sxpenmental 
Procedures.” One al of radioactive proteins was separated by SDS- 
PAGE and identified following fiuorography. C, binding of in vitro 
translated proteins to GST-TAD fusions bound to glutathione-agarose 
beads. Forty id of in vitro translated proteins were incubated with 50 Mg 
of GST fusions and, after washing, eluted by boiling. Similar results 
were obtained when bound proteins were eluted with excess glutathi­
one. In general, a protein was considered to bind specifically if at least 
15-20-fold more radioactive protein was retained by the GST-TAD th«p 
by the GST-Vpu control and 20-40-fold more than for GST as observed 
in at least three separate in vitro binding analyses. Densitoxnemc 
analysts using an EC-210 densitometer was used to quantitate relative 
intensities of bound proteins. Top row, binding of radioactive luciferase 
to GST and GST-TADs; second row, binding of ADA2 to GST, GST-Vpu, 
and GST-TADs; third row, binding of radioactive AD A3 to GST and 
GST-TADs; bottom row, binding of radioactive GCNS to GST, GST-Vpu, 
GST-CAFl. and GST-TADs.
DISCUSSION
TheADA2 Complex Mediates ADRI Activation—ADRI is the  
primary transcriptional activator o f the ADH2 gene and has 
been shown previously (9) and herein to contain four separable 
domains capable o f activating transcription. These individual 
activation domains were found to be highly dependent on a  
functional ADA2 complex for their ability as LexA fusions to
GST-TAOWI------- I GST GST-TAOOI— SI-------------- S
tan 300 no tan3oo an noo i i
“ j a r !  ADA* *
Fig. 2. Stability o f TAD binding to ADAS and GCNS to high salt 
washes. After binding of radioactive proteins to GST-TADs as de- 
scnbed in Fig. I. different wash conditions were used. The number* 
refer to the concentration (in mM) of KAc used in the wash buffer. Bound 
proteins were eluted with boiling and detected with fluorography fol­
lowing SDS-PAGE.
activate a LexA reporter system. Individual LexA-TAD fusions 
were nearly completely blocked for activation when either the 
ADA2 or GCNS gene was deleted. Other LexA-transactivators 
such as LexA-GCN4 have also been shown to function at re­
duced levels when components of the ADA2 complex are de­
leted (17, 34). In contrast, LexA fusions such as LexA-HAP4 are 
aeariy fully transcriptionally active in die absence o f compo­
nents o f the ADA2 complex (17). Full-length ADRI, when fused 
to LexA, also displayed a 20-30-fold reduction in activation  
function when components o f the ADA2 complex were defec­
tive. The observation that LexA-ADRl (full-lengthi retained a 
substantial, albeit reduced, function suggests that the activa­
tion domains in  full-length LexA-ADRl in this context must 
also be capable o f binding targets in addition to the ADA2 
complex.
Several other cofactors known to be required for ADH2 de­
repression were similarly investigated in their requirement for 
LexA-ADRl-TAD function. Defects in components of the SN'F' 
SWT complex had essentially no effect on ADRi activation of 
the LexA-lacZ reporter in contrast to their sizable reduction m 
LexA-GAL4 activation of the same reporter gene (36). The 
CCR4 and CAF1 transcriptional regulatory factors that form a 
multisubunit complex reduced LexA-AD RI -TAD function gen­
erally about 2-3-fold (22, 23). This dependence on CCR4 and 
CAFl appears, however, to represent an indirect requirement, 
since in vitro binding assays have been unable to substantiate 
any specific interaction between ADRI TADs and CCR4 or 
CAFl (23) and since ccr4 and cafl can affect ADH2 expression  
independent of ADRI activity (19, 22). Core transcriptional 
factors may represent other potential targets for ADRi :see 
below).
The ADRI activation of transcription of the ADH2lacZ re­
porter was also severely reduced by defects in the ADA2 com­
plex. In addition, ada2 and gcno deletions reduced the ability o f  
ADRI to activate zheADH2 gene at its chromosomal location. 
These results confirm the importance o f the ADA2 complex in 
ADRl activation. Yet, the fact that an ada2 or gcno disruption 
does not give the same ADH2 phenotype as an ADRI deletion  
highlights the fact that at the ADH2 locus ADRI must also be 
capable o f making additional contacts to activate transcription. 
It should be noted that the effect of ada2 or gcno deletions on 
ADRi activation ability was more severe when the reporter 
gene (either LexA-lacZ or ADH2-lacZ) was on a high copy 
plasmid than when it was positioned in the chromosome (the 
ADH2 locus). The cause of this difference is unclear, although  
the plasmid-borne promoters and the chromosomal promoter 
may differ in term s o f chromatin structure or in assembly of 
ADA2 complex-dependent transcription complexes.
Physical Interaction of ADRI TADs with Components of the 
ADA2 Complex—Each o f the ADRI TADs could selectively bind 
components o f the ADA2 complex. ADA2 interacted with TAD 
II and GCNS w ith each o f the TADs. These interactions appear 
specific for several reasons. First, for the interactions o f GCN5 
and ADA2 to the ADRI TADs to be considered significant, at
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LexA-ACRI-TADfV Jmmm >giiat»-iitoe Remr* teawjc s w y  b u d in f  to a n d i t t a  
^ t n i J  GCNS TFIIB
LexA-ADRl 6 C -7 U 190 3* 17
LexA-ADRl 6*2-701 15 19 12
LexA-ADRl 6*2*691 70 24 10
LexA-ADRl 6*2-694 !S 4.1
LexA-ADRl 6*2-692 20 * 0
LexA-ADRl 6*2-637 24 1.6 1
LexA-ADRl 6*2-679 1
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77i« effect of a TAD TV deletion art ADRI activation 
ADH n  activities were conducted aa described in Table IV. 3-Gaiac- 
tosidase activities were determined as described in Table IT in strain 
EGY1S8. S Z  values were less 15%. LexA-ADRl and LexA-ADRl- 
A642/704 represent LexA-1-202 fused, respectively, to the full-iength 
ADRI protein and the full-length protein whose residues 542-704 have 
been deleted. ADRi and AD R1-A642/704 were expressed to comparable 
extents in. vivo •'data not shown). ADRI. strain 40-iC..4DRl-A642-rO*f. 
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Fig. 4. TFIIB and  TBP binding  to GST-TADs. Binding of ui utro 
translated and radiolabeled TFIIB and TBP to GST-fusion proteins was 
conducted as described in Fig. 1.
2 _8 3
l i a s
Fig. 3. TAD IV activation  ability  correlates with binding  to 
GCN5 an d  TFIIB. A, effect on LexA-ADRl 4642-704) transcriptional 
activity by C-terminal deletions. LexA-ADRl-'642-704) and its deletion 
derivatives were derived as described under ‘Experimental Proce­
dures.* Each derivative was expressed to a comparable extent in yeast 
strain EGYISS os analyzed by Western analysis (data not shown;. 
3-GaIactosidase activities represent averages of at least three separate 
transformants and were assayed as described in Table IL S.E. values 
were less than 20%. The LexA reporter was p!84G in all cases. Relative 
binding to GCN5 or TFIIB compares the amount of radiolabeled GCNS 
or TFIIB bound to the GST-ADRl-TAD IV derivative with the amount 
bound to GST alone. Data for relative binding was obtained following 
densitometnc analysis of the data displayed in B. B, the effect of 
C-terminal deletions of LexA-ADRl-* 642-704) on its ability to bind 
GCN5 or TFIIB. GST-ADRl-TAD IV derivatives of length as indicated 
in die figure were expressed in E. coli and bound to glutathione-agarose 
beads as described under ‘Experimental Procedures/ The bottom row is 
a Coomaasie 31ue-stained SDS-PAGE separation of 50 Mg of m*rh of 
these proteins and illustrates the relative abundance of each of the 
GST-denvatives used for binding. The top row displays the binding of 
GCK5 to each of the GST-derivatives as analyzed by SDS-PAGE and 
fluorography, whereas the middle row displays the binding of TFIIB to 
each of the GST- derivatives.
least 20-fold more GCN5 or ADA2 had to be retained by the 
GST-ADRl-TAD constructs than by th e GST and GST-Vpu 
controls (See legend to Fig. I). In many cases, up to 30-40-fold  
more GCN5 was bound to the target than to the controls: e.g. 
GCNo binding to GST-ADRl-TAD IV and GST-ADRl-TAD OI. 
Second. GCN5 failed to bind other GST fusions such as GST- 
Vpu and GST-CAFl. ADA2 also failed to bind well to TAD I. I ll, 
or IV. Each o f the significant bindings o f an ADRI TAD to 
ADA2 or GCX5 was, moreover, shown to be stable even under 
high sa lt wash conditions. This result suggests that these con­
tacts are not solely dependent on ionic interactions. Finally, the 
GST-ADRl-TADs, whereas they could bind ADA2 or GCN5, 
failed to bind a number of radioacrively labeled proteins includ­
ing luciferase. AD A3, CAFl, CCR4, TBP, and N-TFHB.
Fig. 5. The C terminus of TFIIB binds to TADs I and IV of 
ADRI. Binding studies between GST fusion proteins and radiolabeled 
TFIIB fragments were conducted as described in Fig. I. [npuz repre­
sents Cl/13] of C- or N'-TFIIB used in die binding reaction. C-TFIIB 
contains residues 135-345 of TFUB. and N'-TFIIB contains residues 
1-135 fused to GST. respectively.
The observation that each o f the ADRI TADs ana the full- 
length ADRI are dependent on a functional ADA2 com plex for 
maximal activation suggests that the physical interaction ob­
served between the individual ADRI TADs and the ADA2 and 
GCN5 proteins represents a physiologically significant interac­
tion. This implication is further supported by the TAD IV 
deletion studies. Progressive C-terminal deletions of TAD IV 
reduced TAD IV ability to activate and to directly interact with 
GCN5. The correlation between TAD IV activation and its 
ability to bind GCN5 was nearly exact, suggesting biological 
relevance for the GCN5-TAD IV interaction.
The C-terminal region o f TAD IV (residues 695-704, EY- 
DYEHYQIL), which was required for TAD IV function and 
binding to GCN5, is rich in acidic and bulky hydrophobic amino 
adds. The residues important for transcriptional activation 
have been analyzed for several other activators, and hydropho­
bic residues have increasingly been shown to be crucal for 
activation function f38 -40 ). The hydrophobic residues in the C 
terminus o f  TAD IV may be sim ilarly used for providing con­
tacts or a particular secondary structure that interacts with 
transcriptional factors. However, the actual region of contact 
may be complex, since even derivative LexA-ADRl-(642-679) 
retained some transcriptional activity (Fig. 3A).
In view o f the recent identification of GCN5 as a histone 
acetyltransferase, our results suggest that ADRi recruits the 
ADA2 complex, resulting in increased histone acetylation. Such
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acetylation would presumably relax the audeosom al structure 
at the promoter and facilitate nudeosom al rearrangement. 
Since, upon derepression, ADRI is required a t the ADH2 pro­
moter for nudeosomal removal from the TATA and mRNA 
start site regions (28), ADRI binding to GCNS and ADA2 may 
be one means by which ADRI accomplishes th is. This model 
does not exdude, however, a  role for other nudeosom al rear­
rangement factors such as the SNF/SWI factors. At ADH2, 
snffswi detects also result in  reduced expression. In many 
strains this reduction is only 1.5-fold (25, 27, 41), although at 
least in one strain  a more drastic dependence on SNF/SW I 
was observed (26). A combination o f A D R i recruitm ent o f  
GCN5 and ADA2 and SNF/SW I-fadlitated nudeosom al re­
modeling may, therefore, contribute to A D Rl-dependent ADH2 
expression.
TFIIB Interacts with. TADs I and fV —In. addition to observ­
ing that GCN5 and ADA2 bind to the ADRI TADs, we showed 
that TFIIB could bind TADs I and IV o f A D R I. Again these 
interactions appear specific in that they were stable to high salt 
washes and that TFIIB could not bind TADs II or EH, GST, or 
GST-Vpu. Moreover, die C-terminal region o f TFIIB, but not its 
N terminus, could bind TADs I and IV. In addition, none o f the 
TADs displayed strong binding to TBP. The physiological rel­
evance of these interactions, however, is not certain. For TAD 
IV o f ADRI, deletions that dearly decreased its function also 
directly reduced binding to TFIIB (Fig. 3). T his finding sup­
ports the biological importance o f the interaction between TAD 
IV and TFIIB but does not confirm that TFIIB is a real target 
for TAD IV.
It is possible that the ability of a  TAD to activate represents 
some overall property of “suckmess,’ i.e. the ability to interact 
in die cell with various target factors: GCN5, TFIIB, etc. Many 
target factors for VP16 have been identified (42, 43) as well as 
for the yeast GAL4 activation domain (13). It has recently been 
suggested that this pleiotropic ability o f activators to bind 
many core transcriptional factors and coactivators may repre­
sent a physiological method for an activator in  recruiting the 
transcriptional machinery to a promoter (44).
The multiplicity of ADRI activation dom ains argues simi­
larly that these activation domains could m ake contacts to 
different factors: GCN5 by cne or more dom ains, TFIIB by 
others. The sum total of these interactions and recruitments 
would constitute the ability to promote transcriptional initia­
tion. ADRI activation o f ADH2 and other genes, therefore, 
appears to result from contributions from various factors and 
interactions. Nudeosomal rearrangement promoted by ADRI 
recruitment o f the ADA2 complex and aided by SNF/SW I may 
be one determinant. ADRI binding to transcription factors 
might also play a critical role, and ADRI contacts to TFIIB 
represent one possible example o f this interaction.
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